<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Nephrology - QuizMaster Pro</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}


    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / qBank / Medicine
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">100</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 20359,
    "choices": [
      {
        "id": 81397,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Elevated serum creatinine kinase (CK) </span></span></span></p>"
      },
      {
        "id": 81398,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypercalcemia </span></span></span></p>"
      },
      {
        "id": 81399,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Elevated parathyroid hormone (PTH) </span></span></span></p>"
      },
      {
        "id": 81400,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypokalemia</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old patient with long-standing type 2 diabetes presents with fatigue, pruritus, and elevated creatinine. Renal ultrasound shows bilaterally small kidneys measuring 7 cm in length. Which of the following laboratory findings would best support a diagnosis of CKD rather than acute kidney injury (AKI)?</span></span></p>",
    "unique_key": "Q2818045",
    "question_audio": null,
    "question_video": null,
    "map_id": 20356,
    "difficulty_level": "difficult",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Elevated parathyroid hormone (PTH)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In CKD, decreased production of calcitriol leads to secondary hyperparathyroidism, characterized by elevated PTH levels. Small kidneys on ultrasound suggest chronicity</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Elevated serum creatinine kinase (CK)</span></strong><span style=\"font-size:12.0pt\">: Elevated CK is primarily seen in muscle damage, not CKD. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hypercalcemia</span></strong><span style=\"font-size:12.0pt\">: CKD often leads to <em>hypocalcemia</em> (low calcium) due to impaired vitamin D metabolism, not hypercalcemia. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hypokalemia</span></strong><span style=\"font-size:12.0pt\">: Hypokalemia is not a primary feature of CKD, although it can occur in later stages due to medication use or other factors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CKD is characterized by a gradual decline in kidney function over months or years, while AKI is a sudden onset of kidney dysfunction. Elevated parathyroid hormone (PTH) is a key laboratory marker for CKD due to secondary hyperparathyroidism caused by impaired vitamin D metabolism and phosphate retention.</span></span></span></p>",
    "correct_choice_id": 81399,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 20360,
    "choices": [
      {
        "id": 81401,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sudden onset of flank pain and hematuria</span></span></span></p>"
      },
      {
        "id": 81402,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">History of recent contrast dye exposure </span></span></span></p>"
      },
      {
        "id": 81403,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hyperkalemia and metabolic acidosis </span></span></span></p>"
      },
      {
        "id": 81404,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Progressive worsening of anemia over several months</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following clinical presentations would further support a diagnosis of chronic kidney disease (CKD) rather than acute kidney injury (AKI)?</span></span></p>",
    "unique_key": "Q3107817",
    "question_audio": null,
    "question_video": null,
    "map_id": 20357,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Progressive worsening of anemia over several months</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chronic kidney disease (CKD) is a gradual loss of kidney function over time, often associated with long-standing medical conditions like diabetes and hypertension. The presentation of fatigue, edema, and foamy urine (indicating proteinuria) suggests nephrotic syndrome, a common complication of CKD. The ultrasound findings of normal-sized kidneys with increased echogenicity are consistent with chronic parenchymal damage. The progressive worsening of anemia is also a classic feature of CKD, as declining kidney function leads to reduced erythropoietin production.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Sudden onset of flank pain and hematuria</span></strong><span style=\"font-size:12.0pt\">:<strong> </strong>This presentation is more suggestive of an acute process, such as kidney stones or a urinary tract infection. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. History of recent contrast dye exposure</span></strong><span style=\"font-size:12.0pt\">: Contrast-induced nephropathy is an acute kidney injury that typically occurs within a few days of exposure to contrast dye. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Hyperkalemia and metabolic acidosis</span></strong><span style=\"font-size:12.0pt\">: While these electrolyte imbalances can occur in both AKI and CKD, they are more commonly associated with acute renal failure due to the rapid decline in kidney function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CKD typically presents with a gradual onset of symptoms such as fatigue, edema, and foamy urine, along with progressive anemia due to reduced erythropoietin production. In contrast, AKI presents with a sudden onset of symptoms like flank pain, hematuria, or recent exposure to nephrotoxic agents.</span></span></span></p>",
    "correct_choice_id": 81404,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 20361,
    "choices": [
      {
        "id": 81405,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Acute tubular necrosis (ATN) </span></span></span></p>"
      },
      {
        "id": 81406,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prerenal azotemia </span></span></span></p>"
      },
      {
        "id": 81407,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute interstitial nephritis (AIN) </span></span></span></p>"
      },
      {
        "id": 81408,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Postrenal obstruction</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old man with a history of hypertension presents with acute onset oliguria and elevated creatinine. His blood pressure is 90/60 mmHg, and he reports recent episodes of diarrhea and vomiting. Which of the following is the most likely cause of his AKI?</span></span></p>",
    "unique_key": "Q6552079",
    "question_audio": null,
    "question_video": null,
    "map_id": 20358,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Prerenal azotemia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s history of hypotension, dehydration (from diarrhea and vomiting), and oliguria strongly suggests prerenal AKI, where decreased renal perfusion is the primary cause.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Acute tubular necrosis (ATN):</strong> While possible, it&#39;s less likely in this scenario without a history of nephrotoxic drug exposure or prolonged hypotension</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Acute interstitial nephritis (AIN):</strong> This would typically present with fever, rash, or other signs of allergic reaction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Postrenal obstruction:</strong> Less likely given the absence of urinary symptoms suggestive of obstruction</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand the different causes of acute kidney injury (AKI) and to be able to identify prerenal azotemia as the most likely cause in a patient with hypotension, dehydration, and oliguria. Prerenal azotemia is a functional AKI caused by decreased blood flow to the kidneys, often due to volume depletion or low blood pressure.</span></span></span></p>",
    "correct_choice_id": 81406,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 20362,
    "choices": [
      {
        "id": 81409,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Metformin </span></span></span></p>"
      },
      {
        "id": 81410,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Furosemide </span></span></span></p>"
      },
      {
        "id": 81411,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lisinopril </span></span></span></p>"
      },
      {
        "id": 81412,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aspirin</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old male with a history of heart failure and diabetes mellitus is admitted to the hospital with worsening shortness of breath and leg edema. His serum creatinine has increased from 1.2 mg/dL to 2.5 mg/dL over the past 2 days. Which of the following medications is most likely to have precipitated this acute kidney injury?</span></span></p>",
    "unique_key": "Q3927851",
    "question_audio": null,
    "question_video": null,
    "map_id": 20359,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Lisinopril</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is a common culprit for AKI in patients with pre-existing cardiac or renal dysfunction. ACE inhibitors can decrease glomerular filtration rate (GFR) by reducing efferent arteriolar resistance, particularly in patients with decreased renal perfusion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Metformin</span></strong><span style=\"font-size:12.0pt\">:&nbsp;Metformin is not directly nephrotoxic but can cause lactic acidosis, which can worsen AKI.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.</span></strong> <strong><span style=\"font-size:12.0pt\">Furosemide</span></strong><span style=\"font-size:12.0pt\">:<strong> </strong>Furosemide, a diuretic, might worsen AKI if dehydration is the underlying cause.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Aspirin</span></strong><span style=\"font-size:12.0pt\">:<strong> </strong>Aspirin is not typically associated with AKI unless taken in very high doses.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize that angiotensin-converting enzyme (ACE) inhibitors, such as lisinopril, can precipitate acute kidney injury (AKI) in patients with pre-existing cardiac or renal dysfunction. ACE inhibitors can decrease glomerular filtration rate (GFR) by reducing efferent arteriolar resistance, particularly in patients with decreased renal perfusion.</span></span></span></p>",
    "correct_choice_id": 81411,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 20363,
    "choices": [
      {
        "id": 81413,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 40-year-old with baseline creatinine of 1.2 mg/dL, current creatinine of 2.6 mg/dL, and urine output of 0.4 mL/kg/hour for 18 hours. </span></span></span></p>"
      },
      {
        "id": 81414,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 25-year-old with a baseline creatinine of 0.9 mg/dL, current creatinine of 1.8 mg/dL, and anuria for 14 hours. </span></span></span></p>"
      },
      {
        "id": 81415,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 50-year-old with a baseline creatinine of 0.9 mg/dL, current creatinine of 1.5 mg/dL, and anuria for 10 hours.</span></span></span></p>"
      },
      {
        "id": 81416,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 15-year-old with a decrease in eGFR to 30 mL/min/1.73 m&sup2;.</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following scenarios would classify a patient as having Stage 3 AKI?</span></span></p>",
    "unique_key": "Q9569965",
    "question_audio": null,
    "question_video": null,
    "map_id": 20360,
    "difficulty_level": "difficult",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) A 15-year-old with a decrease in eGFR to 30 mL/min/1.73 m&sup2;.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-144229.png\" style=\"height:594px; width:1000px\" /></p>",
    "correct_choice_id": 81416,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased"
    ]
  },
  {
    "id": 20364,
    "choices": [
      {
        "id": 81417,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Plasma NGAL </span></span></span></p>"
      },
      {
        "id": 81418,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Urinary KIM-1 </span></span></span></p>"
      },
      {
        "id": 81419,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Plasma suPAR </span></span></span></p>"
      },
      {
        "id": 81420,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Urinary TIMP-2 and IGFBP7</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman with a history of diabetes mellitus presents with nausea, vomiting, and oliguria. Her serum creatinine is 2.5 mg/dL, and her urine microscopy shows muddy brown granular casts. Which of the following biomarkers would be most helpful in confirming the diagnosis of acute tubular necrosis (ATN)?</span></span></p>",
    "unique_key": "Q3681912",
    "question_audio": null,
    "question_video": null,
    "map_id": 20361,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Urinary KIM-1</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">KIM-1 is a transmembrane protein that is abundantly expressed in proximal tubular cells injured by ischemia or nephrotoxins. Muddy brown granular casts are a classic finding in ATN, and the presence of KIM-1 in the urine would further support this diagnosis. While NGAL can also be elevated in ATN, it is less specific than KIM-1. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Plasma NGAL</span></strong><span style=\"font-size:12.0pt\">: While NGAL is an early marker for AKI, it&#39;s not specific for ATN and can be elevated in other causes of kidney injury.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Plasma suPAR</span></strong><span style=\"font-size:12.0pt\">: suPAR is more useful in predicting the risk of developing AKI, not confirming ATN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Urinary TIMP-2 and IGFBP7</span></strong><span style=\"font-size:12.0pt\">: These biomarkers are primarily used to predict the risk of severe AKI, not to diagnose the specific cause like ATN</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand the role of urinary biomarkers, specifically KIM-1, in confirming the diagnosis of acute tubular necrosis (ATN). ATN is a common cause of acute kidney injury (AKI), characterized by damage to the renal tubules. Urinary KIM-1 is a highly sensitive and specific biomarker for ATN, as it is released from injured proximal tubular cells.</span></span></span></p>",
    "correct_choice_id": 81418,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "InvestigationBased"
    ]
  },
  {
    "id": 20365,
    "choices": [
      {
        "id": 81421,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antibiotics alone </span></span></span></p>"
      },
      {
        "id": 81422,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intravenous fluids and observation </span></span></span></p>"
      },
      {
        "id": 81423,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Percutaneous nephrostomy tube placement </span></span></span></p>"
      },
      {
        "id": 81424,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ureteral stent placement</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old woman with a history of recurrent urinary tract infections presents with fever, chills, flank pain, and anuria. Ultrasound reveals bilateral hydronephrosis. Which of the following is the most appropriate next step in management?</span></span></p>",
    "unique_key": "Q7019307",
    "question_audio": null,
    "question_video": null,
    "map_id": 20362,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Percutaneous nephrostomy tube placement</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The clinical presentation suggests obstructive uropathy with possible infection. Anuria and bilateral hydronephrosis indicate a significant obstruction. While antibiotics are important for treating the infection, immediate decompression of the urinary tract is critical to prevent further kidney damage. Percutaneous nephrostomy tube placement is the most expedient way to achieve this in a patient with anuria. Ureteral stents might be considered later, but the urgency of the situation necessitates faster decompression.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Antibiotics alone</span></strong><span style=\"font-size:12.0pt\">: Antibiotics alone will not address the underlying obstruction causing the anuria and potential kidney damage. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Intravenous fluids and observation</span></strong><span style=\"font-size:12.0pt\">: Intravenous fluids may worsen hydronephrosis and observation is not appropriate in the setting of anuria. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Ureteral stent placement</span></strong><span style=\"font-size:12.0pt\">: Ureteral stent placement, while a possible treatment, is not as immediate or effective as nephrostomy in relieving anuria</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Obstructive uropathy can quickly lead to irreversible kidney damage, and immediate intervention with a percutaneous nephrostomy tube is often necessary to preserve renal function.</span></span></span></p>",
    "correct_choice_id": 81423,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 20366,
    "choices": [
      {
        "id": 81425,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is at high risk of developing severe AKI requiring dialysis. </span></span></span></p>"
      },
      {
        "id": 81426,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is at moderate risk of AKI, and close monitoring of renal function is necessary. </span></span></span></p>"
      },
      {
        "id": 81427,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is at low risk of severe AKI, as transient ischemia in a normal kidney is unlikely to cause significant damage. </span></span></span></p>"
      },
      {
        "id": 81428,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s risk of AKI cannot be determined without knowing their baseline creatinine level.</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old patient with no prior kidney disease undergoes elective abdominal aortic aneurysm repair requiring cross-clamping of the aorta above the renal arteries. The procedure lasts 45 minutes, and the patient&#39;s blood pressure is well-maintained throughout. Which of the following statements regarding the patient&#39;s risk of acute kidney injury (AKI) is most accurate?</span></span></p>",
    "unique_key": "Q8763567",
    "question_audio": null,
    "question_video": null,
    "map_id": 20363,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) The patient is at low risk of severe AKI, as transient ischemia in a normal kidney is unlikely to cause significant damage.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Healthy kidneys can tolerate short ischemia due to their blood supply, self-regulation, and repair mechanisms. The patient&#39;s healthy kidneys and brief ischemia during surgery suggest a low risk of severe AKI.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. The patient is at high risk of developing severe AKI requiring dialysis</span></strong><span style=\"font-size:12.0pt\">: Severe AKI requiring dialysis is unlikely after a brief, well-managed ischemic event in a healthy individual. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. The patient is at moderate risk of AKI, and close monitoring of renal function is necessary</span></strong><span style=\"font-size:12.0pt\">: While some degree of AKI is possible, it is unlikely to be moderate in this specific scenario with a normal kidney and controlled blood pressure. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. The patient&#39;s risk of AKI cannot be determined without knowing their baseline creatinine level</span></strong><span style=\"font-size:12.0pt\">: While baseline creatinine is helpful, the focus here is the effect of transient ischemia on a normal kidney, not the pre-existing renal function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Factors like adequate blood supply, autoregulation mechanisms, and cellular repair processes contribute to the kidney&#39;s resilience to transient ischemic events.</span></span></span></p>",
    "correct_choice_id": 81427,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette"
    ]
  },
  {
    "id": 20367,
    "choices": [
      {
        "id": 81429,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">FeNa &lt; 1% </span></span></span></p>"
      },
      {
        "id": 81430,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">FeNa 1-2% </span></span></span></p>"
      },
      {
        "id": 81431,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">FeNa 2-3% </span></span></span></p>"
      },
      {
        "id": 81432,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">FeNa &gt; 3%</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old male with a history of chronic heart failure (CHF) on furosemide presents with worsening dyspnea, oliguria, hypotension, and elevated serum creatinine and blood urea nitrogen (BUN) levels. Urinalysis demonstrates dilute urine. The treating physician is suspecting Pre-renal AKI rather than a ATN, which of the following findings supports his diagnosis? </span></span></p>",
    "unique_key": "Q6882057",
    "question_audio": null,
    "question_video": null,
    "map_id": 20364,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) FeNa &lt; 1%</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prerenal AKI arises from reduced renal perfusion, often due to conditions like heart failure or dehydration. In this scenario, the kidneys attempt to conserve sodium and water, leading to a low FeNa (&lt;1%). The patient&#39;s history of CHF, hypotension, and dilute urine on urinalysis are all consistent with prerenal AKI.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. FeNa 1-2%:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This is an indeterminate FeNa range, not definitively diagnostic of either prerenal AKI or ATN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. FeNa 2-3%:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This value suggests intrinsic renal injury, more characteristic of ATN where the tubules are unable to effectively reabsorb sodium.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. FeNa &gt; 3%:</span></strong><span style=\"font-size:12.0pt\">&nbsp;A FeNa greater than 3% strongly suggests intrinsic renal injury, likely ATN, where the tubules have lost their reabsorptive capacity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A low FeNa (&lt;1%) is a hallmark of prerenal AKI, reflecting the kidney&#39;s attempt to conserve sodium in response to decreased renal perfusion.</span></span></span></p>",
    "correct_choice_id": 81429,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 20368,
    "choices": [
      {
        "id": 81433,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Terlipressin </span></span></span></p>"
      },
      {
        "id": 81434,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Octreotide </span></span></span></p>"
      },
      {
        "id": 81435,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Midodrine </span></span></span></p>"
      },
      {
        "id": 81436,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Albumin</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following medications has been shown to potentially prevent AKI in patients with cirrhosis and spontaneous bacterial peritonitis treated with antibiotics?</span></span></p>",
    "unique_key": "Q4334647",
    "question_audio": null,
    "question_video": null,
    "map_id": 20365,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Albumin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Studies have shown that albumin administration can help prevent AKI in patients with SBP undergoing antibiotic treatment. Albumin may improve renal perfusion and reduce inflammation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Terlipressin</span></strong><span style=\"font-size:12.0pt\">:<strong> </strong>Terlipressin works by constricting blood vessels in the splanchnic circulation, which can improve blood flow to the kidneys.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;<strong>Option B. Octreotide</strong>:<strong> </strong>Octreotide reduces splanchnic blood flow and inhibits the release of hormones that worsen kidney function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Midodrine</span></strong><span style=\"font-size:12.0pt\">:<strong> </strong>Midodrine is a vasopressor that helps to increase blood pressure and improve renal perfusion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While these medications may indirectly improve kidney function in some patients, they are not the first-line therapy for preventing AKI in SBP. Albumin administration, on the other hand, has been shown to be more effective in this specific context.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand that albumin administration is an effective intervention for preventing acute kidney injury (AKI) in patients with cirrhosis and spontaneous bacterial peritonitis (SBP) treated with antibiotics. Albumin helps improve renal perfusion and reduce inflammation, thereby mitigating the risk of AKI in this specific population.</span></span></span></p>",
    "correct_choice_id": 81436,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 20369,
    "choices": [
      {
        "id": 81437,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Terlipressin and albumin </span></span></span></p>"
      },
      {
        "id": 81438,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Octreotide and midodrine </span></span></span></p>"
      },
      {
        "id": 81439,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Continuous renal replacement therapy (CRRT) </span></span></span></p>"
      },
      {
        "id": 81440,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Liver transplantation</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old patient with decompensated cirrhosis and refractory ascites presents with oliguria, worsening creatinine, and a low urine sodium concentration (&lt;10 mEq/L). Despite aggressive volume resuscitation with albumin, their renal function continues to decline. Which of the following represents the definitive treatment for their underlying condition?</span></span></p>",
    "unique_key": "Q3922664",
    "question_audio": null,
    "question_video": null,
    "map_id": 20366,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Liver transplantation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hepatorenal syndrome (HRS) is a serious complication of advanced cirrhosis characterized by renal failure without structural kidney damage. The definitive treatment for HRS is liver transplantation, as it addresses the underlying liver dysfunction driving the syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Terlipressin and albumin:</span></strong><span style=\"font-size:12.0pt\">&nbsp;These are vasoconstrictor medications used as a bridge to transplant in HRS,&nbsp;providing temporary improvement in renal function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Octreotide and midodrine:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This combination is another pharmacologic therapy used to manage HRS,&nbsp;but it doesn&#39;t address the root cause.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Continuous renal replacement therapy (CRRT):</span></strong><span style=\"font-size:12.0pt\">&nbsp;While CRRT can provide temporary support for kidney function,&nbsp;it does not treat the underlying cause of HRS and is not a definitive treatment. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize that liver transplantation is the definitive treatment for hepatorenal syndrome (HRS), a serious complication of advanced cirrhosis characterized by renal failure. While pharmacological interventions like terlipressin, albumin, octreotide, and midodrine can provide temporary support, they do not address the underlying liver dysfunction that drives HRS.</span></span></span></p>",
    "correct_choice_id": 81440,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 20370,
    "choices": [
      {
        "id": 81441,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Reduced renal perfusion due to low cardiac output </span></span></span></p>"
      },
      {
        "id": 81442,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increased venous congestion leading to renal venous hypertension </span></span></span></p>"
      },
      {
        "id": 81443,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Neurohormonal activation (RAAS, SNS) </span></span></span></p>"
      },
      {
        "id": 81444,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Direct nephrotoxicity of heart failure medications.</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is NOT a proposed mechanism for the cardiorenal syndrome in ADHF? </span></span></p>",
    "unique_key": "Q6816940",
    "question_audio": null,
    "question_video": null,
    "map_id": 20367,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Reduced renal perfusion due to low cardiac output. </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In most ADHF cases, cardiac output is preserved, so renal hypoperfusion is not the primary mechanism. The other options (venous congestion, neurohormonal activation, and drug effects) are potential contributors to CRS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Increased venous congestion leading to renal venous hypertension:</span></strong><span style=\"font-size:12.0pt\"> In ADHF, the heart&#39;s reduced pumping capacity can lead to a backup of blood in the veins, including those draining the kidneys. This increased pressure can impede blood flow through the kidneys, leading to decreased glomerular filtration rate (GFR) and contributing to CRS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Neurohormonal activation (RAAS, SNS):</span></strong><span style=\"font-size:12.0pt\"> In response to decreased cardiac output, the body activates neurohormonal systems like the renin-angiotensin-aldosterone system (RAAS) and the sympathetic nervous system (SNS). These systems can cause vasoconstriction in the kidneys, further reducing blood flow and contributing to renal dysfunction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Direct nephrotoxicity of heart failure medications:</span></strong><span style=\"font-size:12.0pt\"> Some medications used to treat heart failure, such as certain diuretics and NSAIDs, can be directly toxic to the kidneys, especially in patients with pre-existing renal dysfunction. This can worsen or precipitate AKI in the context of CRS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand the pathophysiology of cardiorenal syndrome (CRS) in acute decompensated heart failure (ADHF), recognizing that reduced renal perfusion due to low cardiac output is NOT a primary mechanism in most cases. Instead, venous congestion, neurohormonal activation, and direct nephrotoxicity of medications are the main contributors to this complex syndrome.</span></span></span></p>",
    "correct_choice_id": 81441,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 20371,
    "choices": [
      {
        "id": 81445,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gadolinium-based contrast agent (GBCA) </span></span></span></p>"
      },
      {
        "id": 81446,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Iodine-based contrast agent </span></span></span></p>"
      },
      {
        "id": 81447,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Barium sulfate </span></span></span></p>"
      },
      {
        "id": 81448,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Air contrast</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient with stage 4 CKD on dialysis develops nephrogenic systemic fibrosis (NSF) after an MRI. Which contrast agent was most likely used?</span></span></span></p>",
    "unique_key": "Q4357763",
    "question_audio": null,
    "question_video": null,
    "map_id": 20368,
    "difficulty_level": "difficult",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Gadolinium-based contrast agent (GBCA)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gadolinium has been associated with development of nephrogenic systemic fibrosis (NSF) in subjects with advanced kidney disease, but the majority of these cases were associated with group I gadolinium-based contrast media. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Iodine-</span></strong><strong><span style=\"font-size:12.0pt\">based contrast agents:&nbsp;</span></strong><span style=\"font-size:12.0pt\">These are primarily used in X-ray and CT imaging. While they can cause contrast-induced nephropathy (CIN), they are not associated with nephrogenic systemic fibrosis (NSF).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Barium</span></strong><strong><span style=\"font-size:12.0pt\"> sulfate:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This contrast agent is used for gastrointestinal imaging and is not typically administered intravenously. Thus, it would not be expected to cause NSF, which is related to systemic exposure to contrast agents.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Air contrast</span></strong><strong><span style=\"font-size:12.0pt\">:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is not a chemical contrast agent, but rather air or carbon dioxide used to enhance the visibility of certain structures in imaging studies. It does not pose a risk of NSF</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand the association between gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF) in patients with advanced kidney disease. Recognizing that GBCA exposure is the primary risk factor for NSF is crucial for preventing this debilitating condition.</span></span></span></p>",
    "correct_choice_id": 81445,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 20372,
    "choices": [
      {
        "id": 81449,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Administer high-dose furosemide before and after the procedure. </span></span></span></p>"
      },
      {
        "id": 81450,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Use low-osmolar or iso-osmolar contrast media. </span></span></span></p>"
      },
      {
        "id": 81451,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pretreat with oral N-acetylcysteine. </span></span></span></p>"
      },
      {
        "id": 81452,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hold metformin for 48 hours before and after the procedure.</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 65-year-old diabetic patient with chronic kidney disease (eGFR 35 mL/min) is scheduled for a coronary angiogram. Which of the following measures is most likely to prevent contrast-induced nephropathy (CIN)?</span></span></span></p>",
    "unique_key": "Q7686090",
    "question_audio": null,
    "question_video": null,
    "map_id": 20369,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Use low-osmolar or iso-osmolar contrast media.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Low or iso-osmolar contrast agents are less nephrotoxic than high-osmolar agents and significantly reduce the risk of CIN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Administer high-dose furosemide before and after the procedure</span></strong><span style=\"font-size:12.0pt\">: Furosemide may actually worsen renal function in this setting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Pretreat with oral N-acetylcysteine</span></strong><span style=\"font-size:12.0pt\">: N-acetylcysteine has limited evidence for CIN prevention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hold metformin for 48 hours before and after the procedure</span></strong><span style=\"font-size:12.0pt\">: Metformin is held due to lactic acidosis risk, not CIN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize the importance of using low-osmolar or iso-osmolar contrast media in patients with chronic kidney disease (CKD) to prevent contrast-induced nephropathy (CIN). While other measures like hydration and withholding certain medications are also important, the choice of contrast agent plays a significant role in mitigating the risk of CIN in these patients.</span></span></span></p>",
    "correct_choice_id": 81450,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 20373,
    "choices": [
      {
        "id": 81453,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute interstitial nephritis </span></span></span></p>"
      },
      {
        "id": 81454,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Contrast-induced nephropathy </span></span></span></p>"
      },
      {
        "id": 81455,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atheroembolic renal disease </span></span></span></p>"
      },
      {
        "id": 81456,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cholesterol emboli syndrome</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 72-year-old man presents with livedo reticularis, blue toes, and acute kidney injury (AKI) after undergoing a coronary angiogram. Which of the following is the most likely diagnosis?</span></span></p>",
    "unique_key": "Q2386367",
    "question_audio": null,
    "question_video": null,
    "map_id": 20370,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Atheroembolic renal disease</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The classic triad of livedo reticularis, blue toes (cyanosis), and AKI after a vascular procedure strongly suggests athero-embolic renal disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Acute interstitial nephritis</span></strong><span style=\"font-size:12.0pt\">: AIN is not associated with livedo reticularis or blue toes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Contrast-induced nephropathy</span></strong><span style=\"font-size:12.0pt\">: CIN typically presents within 24-48 hours of contrast exposure, not days later.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Cholesterol emboli syndrome</span></strong><span style=\"font-size:12.0pt\">: While similar,&nbsp;cholesterol emboli syndrome typically lacks renal involvement</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize the classic presentation of atheroembolic renal disease (AERD), which includes livedo reticularis, blue toes (cyanosis), and acute kidney injury (AKI) following a vascular procedure. This triad of symptoms is highly suggestive of AERD and should prompt further investigation and appropriate management.</span></span></span></p>",
    "correct_choice_id": 81455,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 20374,
    "choices": [
      {
        "id": 81457,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Immune-mediated glomerulonephritis </span></span></span></p>"
      },
      {
        "id": 81458,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Renal artery stenosis </span></span></span></p>"
      },
      {
        "id": 81459,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Renal tubular obstruction by myoglobin casts </span></span></span></p>"
      },
      {
        "id": 81460,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Crystal nephropathy</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with rhabdomyolysis develops acute kidney injury (AKI). Which of the following is the most likely mechanism of AKI in this setting?</span></span></p>",
    "unique_key": "Q8642210",
    "question_audio": null,
    "question_video": null,
    "map_id": 20371,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Renal tubular obstruction by myoglobin casts</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Myoglobin released from damaged muscles can precipitate in the renal tubules, forming casts that obstruct urine flow and cause AKI</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Immune-mediated glomerulonephritis:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This is an inflammatory process affecting the glomeruli (filtering units of the kidney) and is not the primary mechanism in rhabdomyolysis-induced AKI.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Renal artery stenosis:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This is a narrowing of the artery supplying the kidney,&nbsp;which can reduce blood flow and cause kidney damage,&nbsp;but it is not directly related to rhabdomyolysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Crystal nephropathy:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This is caused by the deposition of crystals in the kidneys,&nbsp;most commonly from medications like acyclovir or sulfa drugs,&nbsp;and is not the primary mechanism in rhabdomyolysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The pathophysiology of acute kidney injury (AKI) in rhabdomyolysis, specifically recognizing that renal tubular obstruction by myoglobin casts is the primary mechanism. </span></span></span></p>",
    "correct_choice_id": 81459,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 20375,
    "choices": [
      {
        "id": 81461,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Statins </span></span></span></p>"
      },
      {
        "id": 81462,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Amphetamines </span></span></span></p>"
      },
      {
        "id": 81463,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cocaine </span></span></span></p>"
      },
      {
        "id": 81464,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">All of the above</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following medications is known to increase the risk of rhabdomyolysis?</span></span></p>",
    "unique_key": "Q6014593",
    "question_audio": null,
    "question_video": null,
    "map_id": 20372,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) All of the above</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">All of these medications have been associated with increased risk of rhabdomyolysis through various mechanisms. Statins can cause myopathy, amphetamines can cause hyperthermia and dehydration, and cocaine can lead to seizures and hyperthermia, all of which can trigger muscle breakdown. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Statins, amphetamines, and cocaine are all associated with an increased risk of rhabdomyolysis, a potentially life-threatening condition characterized by the breakdown of skeletal muscle.</span></span></span></p>",
    "correct_choice_id": 81464,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 20376,
    "choices": [
      {
        "id": 81465,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glomerular crescent formation and fibrinoid necrosis </span></span></span></p>"
      },
      {
        "id": 81466,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tubular atrophy and interstitial fibrosis </span></span></span></p>"
      },
      {
        "id": 81467,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Interstitial edema and inflammatory infiltrate with predominantly eosinophils </span></span></span></p>"
      },
      {
        "id": 81468,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thickening of the glomerular basement membrane with immune complex deposits</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old patient presents with acute kidney injury (AKI), fever, maculopapular rash, and arthralgias after recently starting a new medication. A renal biopsy is performed. Which of the following HPE findings will be seen in this patient?</span></span></p>",
    "unique_key": "Q6405001",
    "question_audio": null,
    "question_video": null,
    "map_id": 20373,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Interstitial edema and inflammatory infiltrate with predominantly eosinophils</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute interstitial nephritis is characterized by inflammation in the kidney interstitium (the space between the tubules). The most common findings on a renal biopsy in AIN are:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Interstitial edema:</span></strong><span style=\"font-size:12.0pt\">&nbsp;Fluid accumulation in the interstitium due to inflammation</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Inflammatory infiltrate:</span></strong><span style=\"font-size:12.0pt\">&nbsp;Predominantly lymphocytes and monocytes,&nbsp;but often with a significant number of eosinophils,&nbsp;which is a distinguishing feature of AIN.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Tubulitis:</span></strong><span style=\"font-size:12.0pt\">&nbsp;Inflammation of the renal tubules</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">These findings together suggest an immune-mediated hypersensitivity reaction, which is the typical cause of AIN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Glomerular crescent formation and fibrinoid necrosis:</span></strong><span style=\"font-size:12.0pt\">&nbsp;These are characteristic of rapidly progressive glomerulonephritis (RPGN),&nbsp;a different type of kidney disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Tubular atrophy and interstitial fibrosis:</span></strong><span style=\"font-size:12.0pt\">&nbsp;These findings are more indicative of chronic kidney disease (CKD) rather than the acute inflammatory process of AIN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Thickening of the glomerular basement membrane with immune complex deposits:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This is a common feature of immune-complex mediated glomerulonephritis,&nbsp;not AIN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The characteristic histopathological features of acute interstitial nephritis (AIN) on a renal biopsy, which include interstitial edema, inflammatory infiltrate with predominantly eosinophils, and tubulitis. Recognizing these findings is crucial for the accurate diagnosis and management of AIN, a common cause of acute kidney injury (AKI).</span></span></span></p>",
    "correct_choice_id": 81467,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 20377,
    "choices": [
      {
        "id": 81469,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute glomerulonephritis</span></span></span></p>"
      },
      {
        "id": 81470,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pyelonephritis</span></span></span></p>"
      },
      {
        "id": 81471,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute Interstitial Nephritis</span></span></span></p>"
      },
      {
        "id": 81472,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute tubular necrosis</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old female presents to the emergency department with fever, flank pain, and dysuria. Urinalysis is performed as part of her evaluation, which is shown in the image. Which of the following is the most likely diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-150231.png\" style=\"height:140px; width:300px\" /></span></span></p>",
    "unique_key": "Q2561197",
    "question_audio": null,
    "question_video": null,
    "map_id": 20374,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Pyelonephritis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The image description suggests the presence of white blood cells (WBCs) in the urine, which is consistent with an infectious process in the urinary tract. The clinical presentation of fever, flank pain, and dysuria, along with the urinalysis findings, most likely points to a diagnosis of pyelonephritis (B), an infection of the kidney typically caused by bacteria that have ascended from the lower urinary tract. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A. Acute glomerulonephritis</span></strong><span style=\"font-size:12.0pt\">:</span><strong> </strong><span style=\"font-size:12.0pt\">Acute glomerulonephritis</span><span style=\"font-size:12.0pt\"> is usually characterized by hypertension, hematuria with red blood cell casts, proteinuria, and varying degrees of renal insufficiency, which is not consistent with the presented findings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Acute interstitial nephritis</span></strong><span style=\"font-size:12.0pt\">:</span><strong> </strong><span style=\"font-size:12.0pt\">Acute interstitial nephritis</span><span style=\"font-size:12.0pt\"> typically presents with a rash, fever, and eosinophilia and is often a hypersensitivity reaction to medications. WBC casts may be present, but the clinical symptoms and the absence of medication history make this less likely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Acute tubular necrosis (ATN)</span></strong><span style=\"font-size:12.0pt\">:</span><strong> </strong><span style=\"font-size:12.0pt\">Acute tubular necrosis (ATN)</span><span style=\"font-size:12.0pt\"> often presents with a history of ischemia or nephrotoxic injury, and the urinalysis would typically show muddy brown casts, not the white blood cell casts indicative of infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pyelonephritis is diagnosed based on the combination of clinical symptoms such as fever, flank pain, and dysuria, along with laboratory findings of white blood cell casts in the urine, indicating an infection that has reached the renal pelvis.</span></span></span></p>",
    "correct_choice_id": 81470,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased"
    ]
  },
  {
    "id": 20378,
    "choices": [
      {
        "id": 81473,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Prerenal azotemia </span></span></span></p>"
      },
      {
        "id": 81474,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Acute tubular necrosis (ATN) </span></span></span></p>"
      },
      {
        "id": 81475,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute glomerulonephritis </span></span></span></p>"
      },
      {
        "id": 81476,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Postrenal obstruction</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 72-year-old male with hypertension and type 2 diabetes presents with oliguria, weakness, nausea, and recent initiation of a new anti-hypertensive medication. He has elevated creatinine, BUN, and hyperkalemia. Urinalysis slide is shown below. What&rsquo;s the most likely cause of his kidney injury? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-150358.png\" style=\"height:206px; width:300px\" /></span></span></p>",
    "unique_key": "Q5386845",
    "question_audio": null,
    "question_video": null,
    "map_id": 20375,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Acute tubular necrosis (ATN)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of muddy brown granular casts is a hallmark of ATN. Combined with the patient&#39;s recent medication change (a potential nephrotoxin) and clinical presentation, ATN is the most likely diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Prerenal azotemia:</span></strong><span style=\"font-size:12.0pt\">&nbsp;While possible given the patient&#39;s history,&nbsp;prerenal AKI usually presents with bland urine sediment and a BUN/creatinine ratio &gt;20:1.&nbsp;The presence of granular casts makes this diagnosis less likely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Acute glomerulonephritis:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This typically presents with hematuria,&nbsp;proteinuria,&nbsp;and RBC casts.&nbsp;The absence of these findings and the presence of granular casts make this diagnosis less likely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Postrenal obstruction:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This would likely present with anuria and pain.&nbsp;Ultrasound would be needed to confirm this diagnosis.&nbsp;The presence of granular casts points toward intrinsic renal injury rather than obstruction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The characteristic findings of acute tubular necrosis (ATN) on urinalysis, which include muddy brown granular casts. These casts, in combination with the patient&#39;s clinical presentation and history (recent medication change, elevated creatinine, BUN, and hyperkalemia), can help distinguish ATN from other causes of acute kidney injury (AKI).</span></span></span></p>",
    "correct_choice_id": 81474,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased"
    ]
  },
  {
    "id": 20379,
    "choices": [
      {
        "id": 81477,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intermittent hemodialysis </span></span></span></p>"
      },
      {
        "id": 81478,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Continuous renal replacement therapy (CRRT) </span></span></span></p>"
      },
      {
        "id": 81479,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Peritoneal dialysis </span></span></span></p>"
      },
      {
        "id": 81480,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sustained low-efficiency dialysis (SLED)</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which dialysis modality is most appropriate for a hemodynamically unstable patient with AKI and severe fluid overload?</span></span></p>",
    "unique_key": "Q1330787",
    "question_audio": null,
    "question_video": null,
    "map_id": 20376,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Continuous renal replacement therapy (CRRT)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CRRT is the preferred modality for hemodynamically unstable patients as it provides gentle, continuous fluid and solute removal, minimizing the risk of hypotension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A. Intermittent hemodialysis</span></strong><span style=\"font-size:12.0pt\">: Intermittent hemodialysis can cause hemodynamic instability in these patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Peritoneal dialysis</span></strong><span style=\"font-size:12.0pt\">: Peritoneal dialysis is less efficient and may not be suitable for severe fluid overload.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D.</span> </strong><strong><span style=\"font-size:12.0pt\">Sustained low-efficiency dialysis (SLED)</span></strong><span style=\"font-size:12.0pt\">: SLED is a hybrid modality but may not be tolerated in unstable patients</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand the role of continuous renal replacement therapy (CRRT) as the preferred dialysis modality for hemodynamically unstable patients with acute kidney injury (AKI) and severe fluid overload. CRRT allows for gentle and continuous removal of fluids and solutes, minimizing the risk of hypotension compared to intermittent hemodialysis.</span></span></span></p>",
    "correct_choice_id": 81478,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 20380,
    "choices": [
      {
        "id": 81481,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Severe hyperkalemia unresponsive to medical therapy </span></span></span></p>"
      },
      {
        "id": 81482,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Uremic pericarditis </span></span></span></p>"
      },
      {
        "id": 81483,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Severe fluid overload unresponsive to diuretics </span></span></span></p>"
      },
      {
        "id": 81484,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">BUN level of 120 mg/dL</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is NOT an absolute indication for dialysis in AKI?</span></span></p>",
    "unique_key": "Q4397157",
    "question_audio": null,
    "question_video": null,
    "map_id": 20377,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) BUN level of 120 mg/Dl</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While elevated BUN is a sign of AKI, it is not an absolute indication for dialysis in isolation. The decision to initiate dialysis depends on the clinical context and the presence of other complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Severe hyperkalemia unresponsive to medical therapy</span></strong><span style=\"font-size:12.0pt\">, <strong>Option&nbsp;</strong></span><strong><span style=\"font-size:12.0pt\">B. Uremic pericarditis&nbsp;</span></strong><span style=\"font-size:12.0pt\">and&nbsp;<strong>Option C. Severe fluid overload unresponsive to diuretics</strong>: These are all absolute indications for dialysis in AKI.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The absolute indications for dialysis in AKI, which include severe hyperkalemia unresponsive to medical therapy, uremic pericarditis, and severe fluid overload unresponsive to diuretics. Elevated BUN alone is not an absolute indication, and the decision to initiate dialysis should be based on the overall clinical context and the presence of life-threatening complications.</span></span></span></p>",
    "correct_choice_id": 81484,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 20416,
    "choices": [
      {
        "id": 81625,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Improved renal function </span></span></span></p>"
      },
      {
        "id": 81626,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glomerulosclerosis </span></span></span></p>"
      },
      {
        "id": 81627,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increased renal blood flow </span></span></span></p>"
      },
      {
        "id": 81628,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Decreased intrarenal pressure</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In CKD, the remaining nephrons undergo hyperfiltration and hypertrophy to compensate for lost renal mass. Which of the following is a long-term consequence of these adaptations?</span></span></p>",
    "unique_key": "Q3734304",
    "question_audio": null,
    "question_video": null,
    "map_id": 20413,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Glomerulosclerosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While hyperfiltration and hypertrophy initially help maintain GFR, they lead to increased glomerular capillary pressure and shear stress. Over time, this results in glomerular damage, sclerosis, and ultimately, further nephron loss, accelerating CKD progression.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Improved renal function:</span></strong><span style=\"font-size:12.0pt\"> Hyperfiltration and hypertrophy only temporarily maintain GFR and eventually lead to decline.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Increased renal blood flow:</span></strong><span style=\"font-size:12.0pt\"> While blood flow initially increases, it eventually decreases as nephrons are lost.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Decreased intrarenal pressure:</span></strong><span style=\"font-size:12.0pt\"> Intrarenal pressure actually increases due to hyperfiltration, contributing to damage</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand that while hyperfiltration and hypertrophy are initially compensatory mechanisms in chronic kidney disease (CKD), they ultimately lead to glomerulosclerosis and progressive decline in renal function. Recognizing this pathophysiological process highlights the importance of early intervention and management to slow down the progression of CKD.</span></span></span></p>",
    "correct_choice_id": 81626,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 20417,
    "choices": [
      {
        "id": 81629,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Diabetic nephropathy </span></span></span></p>"
      },
      {
        "id": 81630,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Hypertensive nephrosclerosis </span></span></span></p>"
      },
      {
        "id": 81631,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Lupus nephritis </span></span></span></p>"
      },
      {
        "id": 81632,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">IgA nephropathy</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman with a 10-year history of systemic lupus erythematosus (SLE) presents with fatigue, edema, and hypertension. Laboratory tests reveal proteinuria and an estimated glomerular filtration rate (eGFR) of 40 mL/min/1.73m2. Which of the following is the most likely cause of her chronic kidney disease (CKD)?</span></span></p>",
    "unique_key": "Q2209498",
    "question_audio": null,
    "question_video": null,
    "map_id": 20414,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Lupus nephritis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lupus nephritis is a common complication of SLE and can lead to CKD. The patient&#39;s history of SLE, proteinuria, and declining eGFR strongly suggest this diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Diabetic nephropathy</span></strong><span style=\"font-size:12.0pt\">: Diabetic nephropathy is not associated with SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hypertensive nephrosclerosis</span></strong><span style=\"font-size:12.0pt\">: While hypertension can contribute to CKD, it&#39;s less likely to be the primary cause in a young patient with SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. IgA nephropathy</span></strong><span style=\"font-size:12.0pt\">: IgA nephropathy typically presents with recurrent hematuria, not the constellation of symptoms seen here.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize lupus nephritis as a common and potentially serious complication of systemic lupus erythematosus (SLE). Early detection and management are crucial to preventing the progression of lupus nephritis to chronic kidney disease (CKD) and end-stage renal disease (ESRD).</span></span></span></p>",
    "correct_choice_id": 81631,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 20418,
    "choices": [
      {
        "id": 81633,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CVD is the leading cause of death in patients with CKD. </span></span></span></p>"
      },
      {
        "id": 81634,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The risk of CVD decreases as CKD progresses. </span></span></span></p>"
      },
      {
        "id": 81635,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Traditional CVD risk factors are not important in CKD patients. </span></span></span></p>"
      },
      {
        "id": 81636,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Early-stage CKD patients do not require CVD screening.</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements about cardiovascular disease (CVD) in chronic kidney disease (CKD) is TRUE?</span></span></p>",
    "unique_key": "Q4271201",
    "question_audio": null,
    "question_video": null,
    "map_id": 20415,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) CVD is the leading cause of death in patients with CKD.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CVD is the most common cause of death in CKD patients, often occurring before they reach end-stage renal disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. The risk of CVD decreases as CKD progresses</span></strong><span style=\"font-size:12.0pt\">: The risk of CVD increases as CKD progresses.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Traditional CVD risk factors are not important in CKD patients</span></strong><span style=\"font-size:12.0pt\">: Traditional CVD risk factors are important, but CKD-specific risk factors must also be considered.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Early-stage CKD patients do not require CVD screening</span></strong><span style=\"font-size:12.0pt\">: Early CVD screening and prevention are crucial in CKD patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand the significant impact of cardiovascular disease (CVD) on patients with chronic kidney disease (CKD). It is crucial to recognize that CVD is the leading cause of death in this population and that the risk increases as CKD progresses. This knowledge highlights the importance of early CVD screening and aggressive management of both traditional and CKD-specific risk factors to improve outcomes for patients with CKD.</span></span></span></p>",
    "correct_choice_id": 81633,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 20419,
    "choices": [
      {
        "id": 81637,
        "text": "<p><span style=\"font-size:12.0pt;\">G2A2</span></p>"
      },
      {
        "id": 81638,
        "text": "<p><span style=\"font-size:12.0pt;\">G3aA2</span></p>"
      },
      {
        "id": 81639,
        "text": "<p><span style=\"font-size:12.0pt;\">G3bA2</span></p>"
      },
      {
        "id": 81640,
        "text": "<p><span style=\"font-size:12.0pt;\">G4A2</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old patient presents with a GFR of 50 mL/min/1.73m\u00b2 and an albuminuria level of 150 mg/g. According to the KDIGO 2012 classification, what is the patient's CKD stage?</span></p>",
    "unique_key": "Q1089123",
    "question_audio": null,
    "question_video": null,
    "map_id": 20416,
    "difficulty_level": "difficult",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Correct Answer: B) G3aA2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">According to the KDIGO 2012 classification, CKD staging is determined by both GFR levels and albuminuria categories. With a GFR of 50 mL/min/1.73m\u00b2, this patient falls into the G3a category (45-59 mL/min/1.73m\u00b2), which represents \"mildly to moderately decreased\" kidney function. The albuminuria level of 150 mg/g places the patient in the A2 category (30-300 mg/g), representing \"moderately increased\" albuminuria. Together, these values classify the patient as G3aA2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A) G2A2</strong> - This is incorrect because while the albuminuria category (A2) is appropriate, the GFR of 50 mL/min/1.73m\u00b2 does not fall into G2 range, which is 60-89 mL/min/1.73m\u00b2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C) G3bA2</strong> - This is incorrect because G3b represents a GFR range of 30-44 mL/min/1.73m\u00b2. The patient's GFR of 50 mL/min/1.73m\u00b2 is higher than this range and falls into G3a instead.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D) G4A2</strong> - This is incorrect because G4 represents a GFR range of 15-29 mL/min/1.73m\u00b2, indicating severely decreased kidney function. The patient's GFR of 50 mL/min/1.73m\u00b2 is substantially higher and does not indicate this level of severity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The KDIGO 2012 classification system evaluates CKD by incorporating both GFR and albuminuria levels, providing a more comprehensive assessment of kidney disease severity and progression risk than GFR alone.</span></p>",
    "correct_choice_id": 81638,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased"
    ]
  },
  {
    "id": 20420,
    "choices": [
      {
        "id": 81641,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pericardial friction rub </span></span></span></p>"
      },
      {
        "id": 81642,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">PR depression on ECG </span></span></span></p>"
      },
      {
        "id": 81643,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Elevated troponin levels </span></span></span></p>"
      },
      {
        "id": 81644,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Diffuse ST-segment elevation on ECG</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is NOT a typical finding in uremic pericarditis?</span></span></p>",
    "unique_key": "Q3793405",
    "question_audio": null,
    "question_video": null,
    "map_id": 20417,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Elevated troponin levels</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Uremic pericarditis is not associated with myocardial damage, so troponin levels should be normal.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Pericardial friction rub</span></strong><span style=\"font-size:12.0pt\">, <strong>Option B. PR depression on ECG</strong> and <strong>Option D.</strong></span> <strong><span style=\"font-size:12.0pt\">Diffuse ST-segment elevation on ECG</span></strong><span style=\"font-size:12.0pt\">: These are classic findings in uremic pericarditis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand the typical findings in uremic pericarditis, including pericardial friction rub, PR depression on ECG, and diffuse ST-segment elevation on ECG. It is important to recognize that elevated troponin levels are not a typical finding in uremic pericarditis, as it is not associated with myocardial damage.</span></span></span></p>",
    "correct_choice_id": 81643,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 20421,
    "choices": [
      {
        "id": 81645,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Elevated BUN and creatinine </span></span></span></p>"
      },
      {
        "id": 81646,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hyperphosphatemia </span></span></span></p>"
      },
      {
        "id": 81647,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Uremic toxin accumulation </span></span></span></p>"
      },
      {
        "id": 81648,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Metabolic acidosis</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with CKD stage 5 presents with asterixis, pericarditis, and platelet dysfunction. Which of the following is the most likely explanation for these findings?</span></span></p>",
    "unique_key": "Q9273338",
    "question_audio": null,
    "question_video": null,
    "map_id": 20418,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Uremic toxin accumulation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Asterixis, pericarditis, and platelet dysfunction are all classic manifestations of uremia, caused by the buildup of various uremic toxins in the body when kidney function is severely impaired.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Elevated BUN and creatinine</span></strong><span style=\"font-size:12.0pt\">: BUN and creatinine are markers of kidney function but don&#39;t directly cause these specific symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hyperphosphatemia</span></strong><span style=\"font-size:12.0pt\">: Hyperphosphatemia is a complication of CKD but is not the primary cause of these symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Metabolic acidosis</span></strong><span style=\"font-size:12.0pt\">: Metabolic acidosis can contribute to uremic symptoms but is not the sole cause of these specific findings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize the classic manifestations of uremia, such as asterixis, pericarditis, and platelet dysfunction. These symptoms are caused by the accumulation of uremic toxins in the body due to severely impaired kidney function. Understanding this pathophysiology is crucial for early diagnosis and management of uremia in patients with chronic kidney disease (CKD).</span></span></span></p>",
    "correct_choice_id": 81647,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 20422,
    "choices": [
      {
        "id": 81649,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitamin B12 deficiency </span></span></span></p>"
      },
      {
        "id": 81650,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Iron deficiency </span></span></span></p>"
      },
      {
        "id": 81651,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Decreased erythropoietin production </span></span></span></p>"
      },
      {
        "id": 81652,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Folate deficiency</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old male with stage 4 CKD presents with fatigue and dyspnea on exertion. His hemoglobin level is 9.5 g/dL. Which of the following is the most likely cause of his anemia?</span></span></p>",
    "unique_key": "Q5191680",
    "question_audio": null,
    "question_video": null,
    "map_id": 20419,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Decreased erythropoietin production</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The primary cause of anemia in CKD is decreased erythropoietin (EPO) production due to kidney damage. EPO is a hormone produced by the kidneys that stimulates red blood cell production in the bone marrow. In healthy individuals, the kidneys release EPO in response to low blood oxygen levels. When the kidneys are damaged, they produce less EPO, leading to a decrease in red blood cell production and anemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Vitamin B12 deficiency&nbsp;</span></strong><span style=\"font-size:12.0pt\">and <strong>Option D. folate deficiency</strong>:<strong> </strong>Can also cause anemia, but they are less common causes of anemia in CKD. These deficiencies can be ruled out with blood tests.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Iron deficiency: </span></strong><span style=\"font-size:12.0pt\">Iron deficiency can contribute to anemia in some patients with CKD, but it is not the primary cause. Iron stores are usually assessed before starting treatment for anemia in CKD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand that the primary cause of anemia in chronic kidney disease (CKD) is decreased erythropoietin (EPO) production due to kidney damage. This knowledge is essential for the accurate diagnosis and management of anemia in CKD patients, as it guides the choice of treatment, which often involves administering erythropoiesis-stimulating agents (ESAs) to compensate for the lack of endogenous EPO.</span></span></span></p>",
    "correct_choice_id": 81651,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 20423,
    "choices": [
      {
        "id": 81653,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Calcium carbonate </span></span></span></p>"
      },
      {
        "id": 81654,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Sevelamer </span></span></span></p>"
      },
      {
        "id": 81655,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Cinacalcet </span></span></span></p>"
      },
      {
        "id": 81656,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Calcitriol</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following medications directly suppresses PTH secretion in CKD patients with secondary hyperparathyroidism?</span></span></p>",
    "unique_key": "Q9575869",
    "question_audio": null,
    "question_video": null,
    "map_id": 20420,
    "difficulty_level": "difficult",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Calcitriol</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Calcitriol (active vitamin D) directly suppresses PTH secretion and is used in the management of secondary hyperparathyroidism in CKD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Calcium carbonate</span></strong><span style=\"font-size:12.0pt\">: Calcium carbonate is a phosphate binder,&nbsp;not a PTH suppressant.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Sevelamer</span></strong><span style=\"font-size:12.0pt\">: Sevelamer is a phosphate binder,&nbsp;not a PTH suppressant.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Cinacalcet</span></strong><span style=\"font-size:12.0pt\">: Cinacalcet is a calcimimetic that increases the sensitivity of the parathyroid gland to calcium,&nbsp;indirectly lowering PTH</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand the different classes of medications used to manage secondary hyperparathyroidism in chronic kidney disease (CKD), and to recognize that calcitriol is the only medication listed that directly suppresses parathyroid hormone (PTH) secretion.</span></span></span></p>",
    "correct_choice_id": 81656,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 20424,
    "choices": [
      {
        "id": 81657,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">No treatment is necessary at this time</span></span></span></p>"
      },
      {
        "id": 81658,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Initiate calcium carbonate </span></span></span></p>"
      },
      {
        "id": 81659,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Initiate calcitriol </span></span></span></p>"
      },
      {
        "id": 81660,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Initiate cinacalcet</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with CKD stage 3 has a PTH level of 150 pg/mL and a normal serum calcium level. Which of the following is the most appropriate management strategy?</span></span></p>",
    "unique_key": "Q8367635",
    "question_audio": null,
    "question_video": null,
    "map_id": 20421,
    "difficulty_level": "difficult",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) No treatment is necessary at this time</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">According to current guidelines, a PTH level within 2-9 times the upper limit of normal is acceptable, especially if calcium levels are normal. Therefore, no treatment is indicated at this time.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Initiate calcium carbonate</span></strong><span style=\"font-size:12.0pt\">, <strong>Option C. Initiate calcitriol </strong>and <strong>Option D.</strong> <strong>Initiate</strong> <strong>cinacalcet</strong>: These medications are not indicated unless PTH levels exceed the target range or there are other complications of CKD-MBD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand that not all elevated PTH levels in CKD require immediate intervention. Treatment decisions should be based on the severity of PTH elevation, calcium levels, and the presence of other complications of CKD-mineral bone disease (CKD-MBD).</span></span></span></p>",
    "correct_choice_id": 81657,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 20425,
    "choices": [
      {
        "id": 81661,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Calcium supplements may worsen it. </span></span></span></p>"
      },
      {
        "id": 81662,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Blood vessel blockage is involved. </span></span></span></p>"
      },
      {
        "id": 81663,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pseudomonas infection is common. </span></span></span></p>"
      },
      {
        "id": 81664,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Warfarin use is a risk factor.</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 63-year-old woman with kidney failure on dialysis develops a rapidly progressing, painful nodule on her abdomen that breaks down and forms an open sore (see image). She takes medications for high blood pressure (losartan) and blood clots (warfarin). Which of the following is LEAST likely about her condition?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/13/screenshot-2024-08-13-174056.png\" style=\"height:174px; width:300px\" /></span></span></p>",
    "unique_key": "Q8062224",
    "question_audio": null,
    "question_video": null,
    "map_id": 20422,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Pseudomonas infection is common.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pseudomonas co-infection is typical&nbsp;</span></strong><span style=\"font-size:12.0pt\">is Incorrect. While infection can occur in ulcerated lesions, <em>Staphylococcus aureus</em> is more commonly implicated than Pseudomonas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Calcium supplements may worsen it:</span></strong><span style=\"font-size:12.0pt\"> True. Calcium-based phosphate binders and vitamin D analogs can contribute to the development of calciphylaxis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Calcium supplements may worsen it:</span></strong><span style=\"font-size:12.0pt\"> True. Calciphylaxis is characterized by calcification of small blood vessels leading to ischemia and necrosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Warfarin use is a risk factor:</span></strong><span style=\"font-size:12.0pt\"> True. Warfarin is associated with an increased risk of calciphylaxis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand the key features and risk factors associated with calciphylaxis, a rare but severe complication of chronic kidney disease (CKD). It is important to recognize that while Pseudomonas infection can occur in any open wound, it is not the most common pathogen associated with calciphylaxis. Staphylococcus aureus is more frequently implicated in these infections.</span></span></span></p>",
    "correct_choice_id": 81663,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased"
    ]
  },
  {
    "id": 20426,
    "choices": [
      {
        "id": 81665,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypertension </span></span></span></p>"
      },
      {
        "id": 81666,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Flank or back pain </span></span></span></p>"
      },
      {
        "id": 81667,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gross hematuria </span></span></span></p>"
      },
      {
        "id": 81668,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Urinary tract infection</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the most common presenting symptom in patients with ADPKD?</span></span></p>",
    "unique_key": "Q2235102",
    "question_audio": null,
    "question_video": null,
    "map_id": 20423,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Flank or back pain</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Flank or back pain is the most common presenting symptom in ADPKD, often due to cyst enlargement, hemorrhage, or infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Hypertension</span></strong><span style=\"font-size:12.0pt\">: Hypertension is common but may not be the initial presenting symptom.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Gross hematuria</span></strong><span style=\"font-size:12.0pt\">: Gross hematuria occurs in a significant proportion of patients but is less common than pain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Urinary tract infection</span></strong><span style=\"font-size:12.0pt\">: Urinary tract infections are a complication but not the most common initial presentation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize that flank or back pain is the most common presenting symptom in autosomal dominant polycystic kidney disease (ADPKD). This pain is often due to cyst enlargement, hemorrhage, or infection and may be the first sign of the disease.</span></span></span></p>",
    "correct_choice_id": 81666,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 20427,
    "choices": [
      {
        "id": 81669,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Tolvaptan </span></span></span></p>"
      },
      {
        "id": 81670,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Everolimus </span></span></span></p>"
      },
      {
        "id": 81671,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Octreotide </span></span></span></p>"
      },
      {
        "id": 81672,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Cinacalcet</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following medications is FDA-approved for slowing kidney disease progression in ADPKD?</span></span></p>",
    "unique_key": "Q4839429",
    "question_audio": null,
    "question_video": null,
    "map_id": 20424,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Tolvaptan</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tolvaptan is a vasopressin receptor antagonist that has been shown to slow kidney cyst growth and decline in kidney function in ADPKD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Everolimus</span></strong><span style=\"font-size:12.0pt\">: Everolimus is an mTOR inhibitor under investigation but not FDA-approved for ADPKD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Octreotide</span></strong><span style=\"font-size:12.0pt\">: Octreotide is a somatostatin analogue with potential benefits but not FDA-approved.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12pt\">Option D.</span><span style=\"font-size:14.6667px\">&nbsp;</span></strong><strong style=\"font-size:11pt\"><span style=\"font-size:12.0pt\">Cinacalcet</span></strong><span style=\"font-size:12pt\">: Cinacalcet is used to treat secondary hyperparathyroidism in CKD</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand that tolvaptan is the only FDA-approved medication for slowing the progression of kidney disease in ADPKD. It works by inhibiting vasopressin, which plays a role in cyst growth.</span></span></span></p>",
    "correct_choice_id": 81669,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 20428,
    "choices": [
      {
        "id": 81673,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Brachiocephalic AVF </span></span></span></p>"
      },
      {
        "id": 81674,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Radiocephalic AVF </span></span></span></p>"
      },
      {
        "id": 81675,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Brachiobasilic AVF </span></span></span></p>"
      },
      {
        "id": 81676,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Femoral AVF</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 62-year-old end-stage renal disease (ESRD) patient requires hemodialysis access. Given the need for long-term vascular access, which arteriovenous fistula (AVF) would be the most suitable choice for this patient?</span></span></p>",
    "unique_key": "Q3041825",
    "question_audio": null,
    "question_video": null,
    "map_id": 20425,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Radiocephalic AVF</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For creating a permanent hemodialysis access, a radiocephalic AVF at the wrist is the gold standard choice among nephrologists due to several advantages:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Preservation of future access sites:</span></strong><span style=\"font-size:12.0pt\"> The radial artery and cephalic vein are distal vessels, leaving the brachial artery and basilic vein available for potential future fistula creation if needed.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Lower complication rates:</span></strong><span style=\"font-size:12.0pt\"> Compared to other AVFs, radiocephalic AVFs have a lower risk of complications.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Easier cannulation:</span></strong><span style=\"font-size:12.0pt\"> The radial artery and cephalic vein are typically more superficial and easily accessible for needle insertion during hemodialysis procedures.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Brachiocephalic AVF&nbsp;</span></strong><span style=\"font-size:12.0pt\">and <strong>Option C. Brachiobasilic AVF</strong>: Larger vessels, higher flow, risk of steal syndrome/heart failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Femoral AVF</span></strong><span style=\"font-size:12.0pt\">: Higher infection risk, deeper cannulation</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand the importance of choosing the most suitable arteriovenous fistula (AVF) for long-term hemodialysis access. The radiocephalic AVF at the wrist is generally preferred due to its lower complication rates, easier cannulation, and preservation of future access sites.</span></span></span></p>",
    "correct_choice_id": 81674,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 20429,
    "choices": [
      {
        "id": 81677,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Blood flow rate </span></span></span></p>"
      },
      {
        "id": 81678,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dialysate flow rate </span></span></span></p>"
      },
      {
        "id": 81679,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dialyzer characteristics </span></span></span></p>"
      },
      {
        "id": 81680,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Patient&#39;s age</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is NOT a determinant of hemodialysis efficiency?</span></span></p>",
    "unique_key": "Q4185102",
    "question_audio": null,
    "question_video": null,
    "map_id": 20426,
    "difficulty_level": "difficult",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Patient&#39;s age</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While patient&#39;s age can influence dialysis needs in some ways, it doesn&#39;t directly affect the efficiency of the hemodialysis process itself. Here&#39;s why the other options are important determinants of hemodialysis efficiency:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Blood flow rate:</span></strong><span style=\"font-size:12.0pt\">&nbsp;Higher blood flow rates allow for greater clearance of solutes from the bloodstream across the dialyzer membrane.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Dialysate flow rate:</span></strong><span style=\"font-size:12.0pt\">&nbsp;Faster dialysate flow rates create a steeper concentration gradient between the blood and dialysate, enhancing the diffusion of solutes from the blood into the dialysate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Dialyzer characteristics:</span></strong><span style=\"font-size:12.0pt\">&nbsp;The dialyzer membrane&#39;s surface area, porosity, and permeability all influence how effectively solutes are removed from the blood. For instance, a larger surface area allows for more clearance of solutes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize the key factors that determine hemodialysis efficiency, including blood flow rate, dialysate flow rate, and dialyzer characteristics. While a patient&#39;s age can influence their overall dialysis needs, it doesn&#39;t directly affect the efficiency of the hemodialysis process itself.</span></span></span></p>",
    "correct_choice_id": 81680,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 20430,
    "choices": [
      {
        "id": 81681,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cloudy dialysate </span></span></span></p>"
      },
      {
        "id": 81682,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Abdominal pain </span></span></span></p>"
      },
      {
        "id": 81683,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fever </span></span></span></p>"
      },
      {
        "id": 81684,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypotension</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following findings is NOT typically associated with peritonitis in peritoneal dialysis?</span></span></p>",
    "unique_key": "Q2644229",
    "question_audio": null,
    "question_video": null,
    "map_id": 20427,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Hypotension</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While hypotension can occur in severe sepsis, it is not a typical finding in PD peritonitis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12pt\">Option A.</span><span style=\"font-size:14.6667px\">&nbsp;</span></strong><strong style=\"font-size:11pt\"><span style=\"font-size:12.0pt\">Cloudy dialysate,&nbsp;Option B. Abdominal pain&nbsp;</span></strong><span style=\"font-size:12pt\">and&nbsp;<strong>Option C. Fever</strong>: Cloudy dialysate,&nbsp;abdominal pain,&nbsp;and fever are classic signs of peritonitis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand the typical clinical presentation of peritonitis in peritoneal dialysis, including cloudy dialysate, abdominal pain, and fever. Recognizing these signs and symptoms is crucial for early diagnosis and treatment to prevent complications.</span></span></span></p>",
    "correct_choice_id": 81684,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 20431,
    "choices": [
      {
        "id": 81685,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute intradialytic hypotension </span></span></span></p>"
      },
      {
        "id": 81686,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hemodialysis-associated thrombosis </span></span></span></p>"
      },
      {
        "id": 81687,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dialysis disequilibrium syndrome </span></span></span></p>"
      },
      {
        "id": 81688,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Air embolism during hemodialysis</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 72-year-old man with end-stage renal disease and uremia starts hemodialysis. During the session, he becomes restless, confused, and develops a headache. Which of the following is the most likely cause of his symptoms?</span></span></p>",
    "unique_key": "Q8501243",
    "question_audio": null,
    "question_video": null,
    "map_id": 20428,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Dialysis disequilibrium syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The rapid removal of urea during hemodialysis in a uremic patient can cause an osmotic gradient between the brain and blood, leading to cerebral edema and the neurologic symptoms of dialysis disequilibrium syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Acute intradialytic hypotension:</span></strong><span style=\"font-size:12.0pt\"> This would typically cause dizziness, lightheadedness, or fainting, but not the neurologic symptoms described.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hemodialysis-associated thrombosis:</span></strong><span style=\"font-size:12.0pt\"> This would cause issues with the dialysis access site (e.g., pain, swelling, decreased blood flow) rather than neurologic symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Air embolism during hemodialysis:</span></strong><span style=\"font-size:12.0pt\"> This is a rare but serious complication that would present with sudden respiratory distress, chest pain, and potentially cardiac arrest.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize the signs and symptoms of dialysis disequilibrium syndrome (DDS), a complication that can occur during the initial stages of hemodialysis in patients with uremia. DDS is caused by the rapid removal of urea, creating an osmotic gradient that leads to cerebral edema and neurological symptoms.</span></span></span></p>",
    "correct_choice_id": 81687,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 20432,
    "choices": [
      {
        "id": 81689,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increased potassium concentration </span></span></span></p>"
      },
      {
        "id": 81690,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Decreased potassium concentration </span></span></span></p>"
      },
      {
        "id": 81691,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increased calcium concentration </span></span></span></p>"
      },
      {
        "id": 81692,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Decreased calcium concentration</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with secondary hyperparathyroidism due to end-stage renal disease undergoes a successful parathyroidectomy. During their first hemodialysis session post-surgery, which of the following dialysate modifications would be most appropriate?</span></span></p>",
    "unique_key": "Q4436194",
    "question_audio": null,
    "question_video": null,
    "map_id": 20429,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Increased calcium concentration</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">After parathyroidectomy for secondary hyperparathyroidism, patients are at risk of developing &quot;hungry bone syndrome&quot; (HBS). HBS is characterized by rapid and profound hypocalcemia due to the sudden removal of parathyroid hormone (PTH), which normally increases calcium levels. To compensate for this, the dialysate calcium concentration may be increased to prevent severe hypocalcemia and its associated complications, such as tetany and seizures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A. Increased potassium</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>concentration</strong>:&nbsp;Not relevant to HBS management.&nbsp;Potassium levels may need to be adjusted based on the patient&#39;s serum potassium.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B. Decreased potassium</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>concentration</strong>:&nbsp;This could worsen hypokalemia,&nbsp;which is not a primary concern in HBS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Decreased calcium concentration</span></strong><span style=\"font-size:12.0pt\">:&nbsp;This would exacerbate the existing hypocalcemia in HBS and should be avoided</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand the importance of modifying dialysate calcium concentration after parathyroidectomy in patients with secondary hyperparathyroidism due to end-stage renal disease. Increasing the calcium concentration helps prevent severe hypocalcemia and its associated complications, known as &quot;hungry bone syndrome&quot; (HBS).</span></span></span></p>",
    "correct_choice_id": 81691,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 20433,
    "choices": [
      {
        "id": 81693,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Sirolimus </span></span></span></p>"
      },
      {
        "id": 81694,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Everolimus </span></span></span></p>"
      },
      {
        "id": 81695,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Belatacept </span></span></span></p>"
      },
      {
        "id": 81696,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Basiliximab</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following immunosuppressive medications binds to CD80 and CD86 on antigen-presenting cells, inhibiting T-cell activation? </span></span></p>",
    "unique_key": "Q9775037",
    "question_audio": null,
    "question_video": null,
    "map_id": 20430,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Belatacept </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Belatacept is a costimulatory blockade agent that specifically targets the CD80/CD86-CD28 interaction, a crucial step in T-cell activation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Sirolimus:</span></strong><span style=\"font-size:12.0pt\"> Sirolimus (rapamycin) is an mTOR inhibitor. It works by forming a complex with FKBP-12, which then binds to and inhibits the mTOR protein, thus blocking T-cell proliferation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Everolimus:</span></strong><span style=\"font-size:12.0pt\"> Everolimus is also an mTOR inhibitor and has a similar mechanism of action to sirolimus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Basiliximab:</span></strong><span style=\"font-size:12.0pt\"> Basiliximab is a monoclonal antibody that binds to the IL-2 receptor on activated T cells, preventing their proliferation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand the different mechanisms of action of immunosuppressive medications used in transplantation. Belatacept is unique in its ability to specifically inhibit T-cell activation by blocking the interaction between CD80/CD86 on antigen-presenting cells and CD28 on T cells.</span></span></span></p>",
    "correct_choice_id": 81695,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 20434,
    "choices": [
      {
        "id": 81697,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute tubular necrosis </span></span></span></p>"
      },
      {
        "id": 81698,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Calcineurin inhibitor toxicity </span></span></span></p>"
      },
      {
        "id": 81699,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute T-cell mediated rejection </span></span></span></p>"
      },
      {
        "id": 81700,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antibody-mediated rejection</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 48-year-old kidney transplant recipient, 3 weeks post-transplant, presents with a sudden rise in serum creatinine, decreased urine output, and tenderness over the allograft. Doppler ultrasound shows increased renal artery resistance. Which of the following is the most likely diagnosis?</span></span></p>",
    "unique_key": "Q7037244",
    "question_audio": null,
    "question_video": null,
    "map_id": 20431,
    "difficulty_level": "difficult",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Acute T-cell mediated rejection</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of the following factors strongly suggests acute T-cell mediated rejection:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Timing:</span></strong><span style=\"font-size:12.0pt\">&nbsp;Occurs within the first few weeks to months after transplantation.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Clinical Presentation:</span></strong><span style=\"font-size:12.0pt\">&nbsp;Sudden rise in creatinine,&nbsp;decreased urine output,&nbsp;and tenderness over the allograft.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Doppler Ultrasound:</span></strong><span style=\"font-size:12.0pt\">&nbsp;Increased renal artery resistance is indicative of inflammation and edema in the rejecting kidney.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Acute tubular necrosis (ATN):</span></strong><span style=\"font-size:12.0pt\">&nbsp;ATN usually occurs immediately post-transplant and is less likely weeks later.&nbsp;It would not typically cause allograft tenderness or increased arterial resistance on Doppler.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Calcineurin inhibitor toxicity:</span></strong><span style=\"font-size:12.0pt\">&nbsp;While this can cause elevated creatinine,&nbsp;it usually presents with more gradual onset and less specific symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Antibody-mediated rejection:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This is less likely to occur early post-transplant and typically presents with more severe features like glomerulitis and vascular injury on biopsy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize the clinical presentation and diagnostic findings of acute T-cell mediated rejection in kidney transplant recipients. This type of rejection typically occurs early post-transplant and presents with a sudden rise in creatinine, decreased urine output, allograft tenderness, and increased renal artery resistance on Doppler ultrasound. Differentiating this from other causes of graft dysfunction is crucial for prompt and appropriate intervention.</span></span></span></p>",
    "correct_choice_id": 81699,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 20435,
    "choices": [
      {
        "id": 81701,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Blood culture </span></span></span></p>"
      },
      {
        "id": 81702,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CMV PCR </span></span></span></p>"
      },
      {
        "id": 81703,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Liver biopsy </span></span></span></p>"
      },
      {
        "id": 81704,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lung biopsy</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A kidney transplant recipient with a positive CMV IgG serostatus develops fever, leukopenia, and elevated liver enzymes 4 months post-transplant. Which of the following is the most appropriate diagnostic test to confirm CMV infection?</span></span></p>",
    "unique_key": "Q1688741",
    "question_audio": null,
    "question_video": null,
    "map_id": 20432,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) CMV PCR</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CMV PCR is the most sensitive and specific test for diagnosing CMV infection in transplant recipients. It can detect viral DNA in the blood, allowing for early diagnosis and treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Blood culture</span></strong><span style=\"font-size:12.0pt\">: Blood culture is not useful for diagnosing viral infections like CMV.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Liver biopsy</span></strong><span style=\"font-size:12.0pt\">: Liver biopsy is invasive and not typically needed for diagnosing CMV infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Lung biopsy</span></strong><span style=\"font-size:12.0pt\">: Lung biopsy is not indicated in this scenario as the primary organ involvement is not the lungs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand that CMV PCR is the most sensitive and specific test for diagnosing CMV infection in transplant recipients, allowing for early detection and treatment to prevent complications.</span></span></span></p>",
    "correct_choice_id": 81702,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 20436,
    "choices": [
      {
        "id": 81705,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cytomegalovirus (CMV) &ndash; Valganciclovir </span></span></span></p>"
      },
      {
        "id": 81706,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pneumocystis jirovecii pneumonia (PJP) &ndash; Trimethoprim-sulfamethoxazole (TMP-SMX) </span></span></span></p>"
      },
      {
        "id": 81707,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Aspergillus fumigatus &ndash; Fluconazole </span></span></span></p>"
      },
      {
        "id": 81708,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Nocardia asteroides &ndash; Ganciclovir</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A kidney transplant recipient presents 3 months post-transplant with fever, dry cough, and shortness of breath. Chest X-ray reveals bilateral interstitial infiltrates. Which of the following is the most likely diagnosis and the drug of choice for its prophylaxis?</span></span></p>",
    "unique_key": "Q8855848",
    "question_audio": null,
    "question_video": null,
    "map_id": 20433,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Ans. B) Pneumocystis jirovecii pneumonia (PJP) &ndash; Trimethoprim-sulfamethoxazole (TMP-SMX)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Diagnosis:</span></strong><span style=\"font-size:12.0pt\">&nbsp;The clinical presentation (fever,&nbsp;dry cough,&nbsp;shortness of breath) and chest X-ray findings (bilateral interstitial infiltrates) are characteristic of Pneumocystis jirovecii pneumonia (PJP),&nbsp;a common opportunistic infection in the early post-transplant period.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Prophylaxis:</span></strong><span style=\"font-size:12.0pt\">&nbsp;Trimethoprim-sulfamethoxazole (TMP-SMX) is the preferred prophylactic agent for PJP in transplant recipients.&nbsp;It is typically given for the first 6 months after transplantation and may be continued longer in high-risk patients.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Cytomegalovirus (CMV) &ndash; Valganciclovir</span></strong><span style=\"font-size:12.0pt\">: Cytomegalovirus (CMV) is a common infection after transplantation,&nbsp;but it usually presents with nonspecific symptoms like fever and fatigue,&nbsp;and it does not typically cause the classic chest X-ray findings of PJP.&nbsp;Valganciclovir is used for CMV prophylaxis and treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Aspergillus fumigatus &ndash; Fluconazole</span></strong><span style=\"font-size:12.0pt\">: Aspergillus fumigatus is a mold infection that can cause pulmonary symptoms,&nbsp;but it is less common in the early post-transplant period.&nbsp;Fluconazole is an antifungal medication,&nbsp;not used for PJP prophylaxis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Nocardia asteroides &ndash; Ganciclovir</span></strong><span style=\"font-size:12.0pt\">: Nocardia asteroides is a bacterial infection that can cause pulmonary or disseminated disease,&nbsp;but it is less common than PJP in this setting.&nbsp;Ganciclovir is used for CMV prophylaxis and treatment</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize the clinical presentation and chest X-ray findings of Pneumocystis jirovecii pneumonia (PJP) in kidney transplant recipients and to understand that trimethoprim-sulfamethoxazole (TMP-SMX) is the preferred prophylactic agent for PJP.</span></span></span></p>",
    "correct_choice_id": 81706,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 20437,
    "choices": [
      {
        "id": 81709,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Infection </span></span></span></p>"
      },
      {
        "id": 81710,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Malignancy </span></span></span></p>"
      },
      {
        "id": 81711,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cardiovascular events </span></span></span></p>"
      },
      {
        "id": 81712,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Graft failure</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the leading cause of death in kidney transplant recipients?</span></span></p>",
    "unique_key": "Q3970707",
    "question_audio": null,
    "question_video": null,
    "map_id": 20434,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Cardiovascular events</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While all of the listed options are potential causes of death in kidney transplant recipients, cardiovascular events are the leading cause, accounting for approximately 29% of deaths in this population. This patient&#39;s presentation is concerning for post-transplant lymphoproliferative disorder (PTLD), a type of malignancy that is more common in transplant recipients due to immunosuppression. However, even with PTLD, cardiovascular events remain the most likely cause of death.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Infection:</span></strong><span style=\"font-size:12.0pt\">&nbsp;While infection is a significant cause of mortality in transplant recipients (18%),&nbsp;it is not as common as cardiovascular events.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Malignancy</strong>: Malignancy, including PTLD, is also a concern for transplant recipients (17%), but it is still less common than cardiovascular events.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Graft failure:</span></strong><span style=\"font-size:12.0pt\">&nbsp;While graft failure can lead to death,&nbsp;it is not as frequent a cause as cardiovascular events.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand that cardiovascular events are the leading cause of death in kidney transplant recipients, highlighting the importance of cardiovascular risk assessment and management in this population.</span></span></span></p>",
    "correct_choice_id": 81711,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 53732,
    "choices": [
      {
        "id": 214401,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Diuretic excess </span></span></span></p>"
      },
      {
        "id": 214402,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mineralocorticoid deficiency </span></span></span></p>"
      },
      {
        "id": 214403,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cerebral salt wasting syndrome </span></span></span></p>"
      },
      {
        "id": 214404,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Syndrome of inappropriate antidiuretic hormone secretion (SIADH)</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is NOT a cause of hypovolemic hyponatremia with a urine sodium level greater than 20 mEq/L?</span></span></p>",
    "unique_key": "Q2069933",
    "question_audio": null,
    "question_video": null,
    "map_id": 25334,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Syndrome of inappropriate antidiuretic hormone secretion (SIADH)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">SIADH is a euvolemic state with a urine sodium level greater than 20 mEq/L. It is caused by excessive release of antidiuretic hormone (ADH), which leads to water retention and dilutional hyponatremia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;Diuretic excess,&nbsp;Option B.&nbsp;Mineralocorticoid deficiency,&nbsp;and Option C.&nbsp;Cerebral salt wasting syndrome</span></strong><span style=\"font-size:12.0pt\"> are all causes of hypovolemic hyponatremia with a urine sodium level greater than 20 mEq/L.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand the different types of hyponatremia and their associated urine sodium levels. Hypovolemic hyponatremia with a urine sodium level greater than 20 mEq/L is caused by renal sodium loss (e.g., diuretics, mineralocorticoid deficiency) or extrarenal sodium loss (e.g., cerebral salt wasting). SIADH is euvolemic hyponatremia with high urine sodium due to excessive water retention.</span></span></span></p>",
    "correct_choice_id": 214404,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 53733,
    "choices": [
      {
        "id": 214405,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Syndrome of inappropriate antidiuretic hormone secretion (SIADH) </span></span></span></p>"
      },
      {
        "id": 214406,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypothyroidism </span></span></span></p>"
      },
      {
        "id": 214407,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Primary adrenal insufficiency </span></span></span></p>"
      },
      {
        "id": 214408,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypervolemic hyponatremia</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 68-year-old woman with a history of congestive heart failure presents with confusion, nausea, and a serum sodium level of 128 mEq/L. Her physical exam reveals jugular venous distention and bilateral crackles on lung auscultation. Which of the following is the most likely cause of her hyponatremia?</span></span></p>",
    "unique_key": "Q5476302",
    "question_audio": null,
    "question_video": null,
    "map_id": 25335,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Hypervolemic hyponatremia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s presentation of heart failure with fluid overload (JVD, crackles) and low serum sodium suggests hypervolemic hyponatremia. This is caused by excess water retention relative to sodium, often seen in heart failure and other edematous states.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Syndrome of inappropriate antidiuretic hormone secretion (SIADH):</span></strong><span style=\"font-size:12.0pt\"> While SIADH can cause hyponatremia, it is typically euvolemic (normal fluid volume status) and does not present with signs of fluid overload like JVD and crackles.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hypothyroidism:</span></strong><span style=\"font-size:12.0pt\"> Hypothyroidism can cause mild hyponatremia, but it is usually not associated with the degree of hyponatremia and fluid overload seen in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Primary adrenal insufficiency:</span></strong><span style=\"font-size:12.0pt\"> Primary adrenal insufficiency can cause hyponatremia due to aldosterone deficiency. However, it typically presents with additional symptoms such as fatigue, weight loss, and hypotension, which are not present in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize the clinical presentation of hypervolemic hyponatremia, which is characterized by low serum sodium, fluid overload (JVD, edema, crackles), and often associated with underlying conditions like heart failure.</span></span></span></p>",
    "correct_choice_id": 214408,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 53735,
    "choices": [
      {
        "id": 214413,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">SIADH </span></span></span></p>"
      },
      {
        "id": 214414,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Primary polydipsia </span></span></span></p>"
      },
      {
        "id": 214415,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypothyroidism </span></span></span></p>"
      },
      {
        "id": 214416,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cirrhosis</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is NOT a common cause of euvolemic hyponatremia?</span></span></p>",
    "unique_key": "Q3262646",
    "question_audio": null,
    "question_video": null,
    "map_id": 25337,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Cirrhosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cirrhosis is typically associated with hypervolemic hyponatremia due to ascites and fluid retention. SIADH, primary polydipsia, and hypothyroidism are all potential causes of euvolemic hyponatremia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. SIADH (Syndrome of Inappropriate Antidiuretic Hormone secretion):</span></strong><span style=\"font-size:12.0pt\"> In SIADH, excess antidiuretic hormone (ADH) leads to water retention, diluting sodium levels. However, the body&#39;s total sodium content remains normal, resulting in euvolemic hyponatremia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Primary polydipsia:</span></strong><span style=\"font-size:12.0pt\"> Excessive water intake in individuals with normal kidney function can overwhelm the kidneys&#39; ability to excrete water, leading to dilutional hyponatremia without changes in total body sodium (euvolemic).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Hypothyroidism:</span></strong><span style=\"font-size:12.0pt\"> In hypothyroidism, decreased thyroid hormone levels can impair water excretion by the kidneys, leading to water retention and dilutional hyponatremia without changes in total body sodium (euvolemic).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand that cirrhosis is typically associated with hypervolemic hyponatremia, not euvolemic hyponatremia. Euvolemic hyponatremia is usually caused by SIADH, primary polydipsia, or hypothyroidism.</span></span></span></p>",
    "correct_choice_id": 214416,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 53737,
    "choices": [
      {
        "id": 214421,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fluid restriction </span></span></span></p>"
      },
      {
        "id": 214422,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Normal saline infusion </span></span></span></p>"
      },
      {
        "id": 214423,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypertonic saline infusion </span></span></span></p>"
      },
      {
        "id": 214424,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Demeclocycline</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with severe hyponatremia (serum sodium 115 mEq/L) develops seizures and altered mental status. Which of the following is the most appropriate treatment for this patient?</span></span></p>",
    "unique_key": "Q6128630",
    "question_audio": null,
    "question_video": null,
    "map_id": 25339,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Hypertonic saline infusion</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Severe symptomatic hyponatremia is a medical emergency. Hypertonic saline (3%) is the treatment of choice to rapidly raise serum sodium levels and prevent further neurological complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Fluid restriction</span></strong><span style=\"font-size:12.0pt\">: Fluid restriction is appropriate for mild hyponatremia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Normal saline infusion</span></strong><span style=\"font-size:12.0pt\">: Normal saline is not effective in severe hyponatremia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Demeclocycline</span></strong><span style=\"font-size:12.0pt\">: Demeclocycline is used for chronic SIADH,&nbsp;not acute,&nbsp;severe hyponatremia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize severe symptomatic hyponatremia as a medical emergency requiring prompt treatment with hypertonic saline (3%) to rapidly raise serum sodium levels and prevent neurological complications.</span></span></span></p>",
    "correct_choice_id": 214423,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 53739,
    "choices": [
      {
        "id": 214429,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chlorpropamide </span></span></span></p>"
      },
      {
        "id": 214430,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Carbamazepine </span></span></span></p>"
      },
      {
        "id": 214431,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hydrochlorothiazide </span></span></span></p>"
      },
      {
        "id": 214432,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Selective serotonin reuptake inhibitors (SSRIs)</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following medications is NOT associated with the development of SIAD?</span></span></p>",
    "unique_key": "Q1140967",
    "question_audio": null,
    "question_video": null,
    "map_id": 25341,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Hydrochlorothiazide</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hydrochlorothiazide is a thiazide diuretic that can cause hyponatremia, but not through SIAD. It works by inhibiting sodium reabsorption in the kidney, leading to increased water excretion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Chlorpropamide</span></strong><span style=\"font-size:12.0pt\">,&nbsp;<strong>Option B. Carbamazepine</strong>,&nbsp;and <strong>Option D. Selective serotonin reuptake inhibitors (SSRIs</strong>) are listed in the table as drugs that can stimulate ADH release or enhance its action,&nbsp;leading to SIAD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize that hydrochlorothiazide is not associated with the development of SIADH, while other medications like chlorpropamide, carbamazepine, and SSRIs can stimulate ADH release or enhance its action, leading to SIADH. Understanding the potential side effects of medications is crucial for accurate diagnosis and management of hyponatremia.</span></span></span></p>",
    "correct_choice_id": 214431,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 53741,
    "choices": [
      {
        "id": 214437,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypertonic saline (3%) infusion </span></span></span></p>"
      },
      {
        "id": 214438,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fluid restriction to 500-800 ml/day </span></span></span></p>"
      },
      {
        "id": 214439,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Demeclocycline</span></span></span></p>"
      },
      {
        "id": 214440,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tolvaptan</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old patient with small cell lung cancer presents with chronic hyponatremia (125 mEq/L) due to SIADH. Which of the following is the most appropriate initial treatment?</span></span></p>",
    "unique_key": "Q2535558",
    "question_audio": null,
    "question_video": null,
    "map_id": 25343,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Fluid restriction to 500-800 ml/day</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The initial treatment for most cases of chronic SIADH is fluid restriction. This limits water intake, allowing the body to naturally excrete excess water and gradually correct the hyponatremia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Hypertonic saline (3%) infusion</span></strong><span style=\"font-size:12.0pt\">: Hypertonic saline is reserved for severe symptomatic hyponatremia or rapid correction in specific situations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Demeclocycline</span></strong><span style=\"font-size:12.0pt\">: Demeclocycline is a second-line agent used if fluid restriction fails.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Tolvaptan</strong>: Tolvaptan is a vasopressin receptor antagonist,&nbsp;also considered second-line after fluid restriction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand that fluid restriction is the most appropriate initial treatment for chronic SIADH, as it allows for gradual correction of hyponatremia without the risks associated with more aggressive therapies like hypertonic saline or medications.</span></span></span></p>",
    "correct_choice_id": 214438,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 53743,
    "choices": [
      {
        "id": 214445,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Syndrome of inappropriate antidiuretic hormone secretion (SIADH) </span></span></span></p>"
      },
      {
        "id": 214446,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cerebral salt wasting (CSW) </span></span></span></p>"
      },
      {
        "id": 214447,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Primary polydipsia </span></span></span></p>"
      },
      {
        "id": 214448,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute tubular necrosis (ATN)</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old man with a recent subarachnoid hemorrhage develops hyponatremia, hypotension, and polyuria. His urine sodium is 50 mEq/L. Which of the following is the most likely diagnosis?</span></span></p>",
    "unique_key": "Q9560697",
    "question_audio": null,
    "question_video": null,
    "map_id": 25345,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Cerebral salt wasting (CSW)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of hyponatremia, hypovolemia (hypotension), and high urine sodium (&gt;20 mEq/L) in a patient with recent brain injury strongly suggests CSW.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Syndrome of inappropriate antidiuretic hormone secretion (SIADH)</span></strong><span style=\"font-size:12.0pt\">:&nbsp;Typically euvolemic (normal fluid status) with low urine sodium (&lt;20 mEq/L).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Primary polydipsia</span></strong><span style=\"font-size:12.0pt\">:&nbsp;Euvolemic with low urine sodium.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Acute tubular necrosis (ATN)</span></strong><span style=\"font-size:12.0pt\">:&nbsp;Would cause oliguria,&nbsp;not polyuria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize the characteristic features of cerebral salt wasting (CSW), a syndrome that can occur after brain injury and presents with hyponatremia, hypovolemia, and elevated urine sodium. Distinguishing CSW from other causes of hyponatremia, such as SIADH, is crucial for appropriate management.</span></span></span></p>",
    "correct_choice_id": 214446,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 53744,
    "choices": [
      {
        "id": 214449,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fluid restriction </span></span></span></p>"
      },
      {
        "id": 214450,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypertonic saline </span></span></span></p>"
      },
      {
        "id": 214451,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Normal saline </span></span></span></p>"
      },
      {
        "id": 214452,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Demeclocycline</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with hypovolemic hyponatremia and a urine sodium of 10 mEq/L should be treated with:</span></span></p>",
    "unique_key": "Q2022313",
    "question_audio": null,
    "question_video": null,
    "map_id": 25346,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Normal saline</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypovolemic hyponatremia with low urine sodium suggests extrarenal salt loss. Normal saline replenishes both salt and water to correct the hypovolemia and hyponatremia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Fluid restriction</span></strong><span style=\"font-size:12.0pt\">: Fluid restriction would worsen hypovolemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hypertonic saline</span></strong><span style=\"font-size:12.0pt\">: Hypertonic saline is not the initial choice for hypovolemic hyponatremia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Demeclocycline</span></strong><span style=\"font-size:12.0pt\">: Demeclocycline is not indicated for hypovolemic hyponatremia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand that hypovolemic hyponatremia with low urine sodium (&lt;20 mEq/L) indicates extrarenal salt loss and should be treated with normal saline to restore both volume and sodium balance.</span></span></span></p>",
    "correct_choice_id": 214451,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 53746,
    "choices": [
      {
        "id": 214457,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">T2 hyperintensity in the basal ganglia </span></span></span></p>"
      },
      {
        "id": 214458,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gadolinium enhancement in the thalamus </span></span></span></p>"
      },
      {
        "id": 214459,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">T2 hyperintensity in the central pons with sparing of the periphery </span></span></span></p>"
      },
      {
        "id": 214460,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Diffusion restriction in the cerebral cortex</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old man with a history of alcohol abuse presents with progressive weakness and spasticity in his legs two days after rapid correction of severe hyponatremia. Given the likely diagnosis, Which of the following neuroimaging findings would be present in the MRI? </span></span></p>",
    "unique_key": "Q6401593",
    "question_audio": null,
    "question_video": null,
    "map_id": 25348,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) T2 hyperintensity in the central pons with sparing of the periphery</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This is the classic MRI finding in CPM, where demyelination occurs predominantly in the central pons.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-family:Calibri,sans-serif\"><strong style=\"font-size:11pt\"><span style=\"font-size:12.0pt\">Option A. T2 hyperintensity in the basal ganglia&nbsp;</span></strong><span style=\"font-size:12pt\">and&nbsp;<strong>Option&nbsp;</strong></span><strong><span style=\"font-size:12pt\">B.</span><span style=\"font-size:14.6667px\">&nbsp;</span></strong><strong style=\"font-size:11pt\"><span style=\"font-size:12.0pt\">Gadolinium enhancement in</span></strong> <strong style=\"font-size:11pt\"><span style=\"font-size:12.0pt\">the</span></strong> <strong style=\"font-size:11pt\"><span style=\"font-size:12.0pt\">thalamus</span></strong><span style=\"font-size:12pt\">: These findings are not specific to CPM.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Diffusion restriction in the cerebral cortex</span></strong><span style=\"font-size:12.0pt\">: Diffusion restriction can be seen in various acute brain lesions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand the classic MRI findings of central pontine myelinolysis (CPM), which include T2 hyperintensity in the central pons with sparing of the periphery. This is a crucial diagnostic feature that can help differentiate CPM from other neurological conditions.</span></span></span></p>",
    "correct_choice_id": 214459,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 53747,
    "choices": [
      {
        "id": 214461,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intravenous mannitol </span></span></span></p>"
      },
      {
        "id": 214462,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oral urea </span></span></span></p>"
      },
      {
        "id": 214463,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Re-lowering of plasma sodium concentration with desmopressin (DDAVP) and/or free water </span></span></span></p>"
      },
      {
        "id": 214464,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Corticosteroids</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the most effective intervention to prevent or attenuate osmotic demyelination syndrome (ODS) after overly rapid correction of hyponatremia?</span></span></p>",
    "unique_key": "Q3844340",
    "question_audio": null,
    "question_video": null,
    "map_id": 25349,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Re-lowering of plasma sodium concentration with desmopressin (DDAVP) and/or free water</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">If hypernatremia develops after rapid correction, re-lowering the serum sodium with DDAVP and/or free water can reverse the osmotic gradient and potentially prevent or lessen the severity of ODS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Intravenous mannitol</span></strong><span style=\"font-size:12.0pt\">: Mannitol may worsen osmotic stress.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Oral urea</span></strong><span style=\"font-size:12.0pt\">: Oral urea is not indicated in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Corticosteroids</span></strong><span style=\"font-size:12.0pt\">: Corticosteroids have no proven benefit in preventing ODS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize that re-lowering of plasma sodium concentration with desmopressin (DDAVP) and/or free water is the most effective intervention for preventing or attenuating osmotic demyelination syndrome (ODS) after overly rapid correction of hyponatremia. This is based on the principle of reversing the osmotic gradient that causes myelinolysis.</span></span></span></p>",
    "correct_choice_id": 214463,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 53749,
    "choices": [
      {
        "id": 214469,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2 liters </span></span></span></p>"
      },
      {
        "id": 214470,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">4 liters </span></span></span></p>"
      },
      {
        "id": 214471,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">6 liters </span></span></span></p>"
      },
      {
        "id": 214472,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">8 liters</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old man with dementia presents with lethargy, decreased oral intake for two days, and a serum sodium of 160 mEq/L. His weight is 70kg. Assuming total body water (TBW) is 60% of his body weight, what is his estimated free water deficit?</span></span></p>",
    "unique_key": "Q4317165",
    "question_audio": null,
    "question_video": null,
    "map_id": 25351,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) 6 liters</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The formula for calculating free water deficit is:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Free water deficit = TBW x [(Serum Na+ - 140) / 140]</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">TBW = 70 kg x 0.60 = 42 L</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Free water deficit = 42 L x [(160 mEq/L - 140 mEq/L) / 140 mEq/L] = 6 L</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. 2 liters, Option B. 4 liters&nbsp;</span></strong><span style=\"font-size:12.0pt\">and<strong> Option D. 8 liters:</strong>&nbsp;These options represent incorrect calculations of the free water deficit using the formula above.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand how to calculate free water deficit in a patient with hypernatremia. This is a crucial step in determining the appropriate amount of fluid replacement needed to correct the hypernatremia safely.</span></span></span></p>",
    "correct_choice_id": 214471,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 53751,
    "choices": [
      {
        "id": 214477,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Peaked T waves </span></span></span></p>"
      },
      {
        "id": 214478,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prolonged PR interval</span></span></span></p>"
      },
      {
        "id": 214479,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">U waves </span></span></span></p>"
      },
      {
        "id": 214480,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Widened QRS complex</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is NOT a typical ECG finding in hyperkalemia?</span></span></p>",
    "unique_key": "Q7795925",
    "question_audio": null,
    "question_video": null,
    "map_id": 25352,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) U waves</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">U waves</span></strong><span style=\"font-size:12.0pt\"> are typically seen in hypokalemia, not hyperkalemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12pt\">Option A.</span><span style=\"font-size:14.6667px\">&nbsp;</span></strong><strong style=\"font-size:11pt\"><span style=\"font-size:12.0pt\">Peaked T waves,&nbsp;Option B. Prolonged PR interval&nbsp;</span></strong><span style=\"font-size:12pt\">and&nbsp;<strong>Option&nbsp;</strong></span><strong style=\"font-size:11pt\"><span style=\"font-size:12.0pt\">D. Widened QRS</span></strong> <strong style=\"font-size:11pt\"><span style=\"font-size:12.0pt\">complex</span></strong><span style=\"font-size:12pt\">: These are all characteristic ECG changes seen in hyperkalemia.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize the characteristic ECG findings in hyperkalemia, which include peaked T waves, prolonged PR interval, and widened QRS complex. U waves, on the other hand, are typically associated with hypokalemia. Understanding these ECG changes is crucial for the prompt diagnosis and management of hyperkalemia, a potentially life-threatening electrolyte imbalance.</span></span></span></p>",
    "correct_choice_id": 214479,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 53753,
    "choices": [
      {
        "id": 214485,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Administer oral sodium polystyrene sulfonate (Kayexalate) </span></span></span></p>"
      },
      {
        "id": 214486,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Administer intravenous calcium gluconate </span></span></span></p>"
      },
      {
        "id": 214487,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Initiate hemodialysis </span></span></span></p>"
      },
      {
        "id": 214488,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Administer intravenous insulin and glucose</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old patient with chronic kidney disease presents to the emergency department with muscle weakness, peaked T waves on ECG, and a serum potassium level of 7.0 mEq/L. Which of the following is the most appropriate immediate intervention?</span></span></p>",
    "unique_key": "Q5285232",
    "question_audio": null,
    "question_video": null,
    "map_id": 25353,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Administer intravenous calcium gluconate</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intravenous calcium gluconate is the first-line treatment for hyperkalemia with ECG changes to stabilize the cardiac membrane and prevent life-threatening arrhythmias.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Administer oral sodium polystyrene sulfonate (</span></strong><strong><span style=\"font-size:12.0pt\">Kayexalate)</span></strong><span style=\"font-size:12.0pt\">: Kayexalate is a potassium binder but works too slowly for acute hyperkalemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Initiate hemodialysis</span></strong><span style=\"font-size:12.0pt\">: Hemodialysis is effective but may not be immediately available.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Administer intravenous insulin and glucose</span></strong><span style=\"font-size:12.0pt\">: Insulin and glucose shift potassium intracellularly,&nbsp;but calcium should be given first to protect the heart.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize the importance of administering intravenous calcium gluconate as the immediate intervention for patients presenting with hyperkalemia and ECG changes. This medication acts quickly to stabilize the cardiac membrane and protect against potentially fatal arrhythmias. While other options like Kayexalate, hemodialysis, and insulin/glucose can help lower potassium levels, they may not act rapidly enough to prevent immediate cardiac complications.</span></span></span></p>",
    "correct_choice_id": 214486,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 53755,
    "choices": [
      {
        "id": 214493,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Peaked T waves </span></span></span></p>"
      },
      {
        "id": 214494,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Shortened QT interval </span></span></span></p>"
      },
      {
        "id": 214495,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prominent U waves </span></span></span></p>"
      },
      {
        "id": 214496,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ST segment elevation</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old woman with a history of chronic diarrhea presents with muscle weakness, fatigue, and palpitations. Her serum potassium is 2.8 mEq/L. Which of the following ECG findings would be most consistent with her presentation?</span></span></p>",
    "unique_key": "Q2693156",
    "question_audio": null,
    "question_video": null,
    "map_id": 25354,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Prominent U waves</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prominent U waves are a hallmark of hypokalemia, especially when severe (&lt;2.7 mEq/L). The patient&#39;s history of chronic diarrhea likely caused potassium loss, leading to hypokalemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Peaked T waves</span></strong><span style=\"font-size:12.0pt\">: Peaked T waves are associated with hyperkalemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Shortened QT interval</span></strong><span style=\"font-size:12.0pt\">: Hypokalemia typically prolongs the QT interval,&nbsp;not shortens it.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. ST segment elevation</span></strong><span style=\"font-size:12.0pt\">: ST segment elevation is typically seen in myocardial infarction or pericarditis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize the characteristic ECG finding of hypokalemia, which is the presence of prominent U waves. This finding, along with the patient&#39;s symptoms (muscle weakness, fatigue, palpitations) and history of chronic diarrhea (a potential cause of potassium loss), helps confirm the diagnosis of hypokalemia.</span></span></span></p>",
    "correct_choice_id": 214495,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 53756,
    "choices": [
      {
        "id": 214497,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increased urinary potassium excretion due to glycosuria </span></span></span></p>"
      },
      {
        "id": 214498,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vomiting-induced potassium loss </span></span></span></p>"
      },
      {
        "id": 214499,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Insulin deficiency-induced intracellular shift of potassium </span></span></span></p>"
      },
      {
        "id": 214500,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Shift of potassium into cells in exchange for hydrogen ions</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old man with poorly controlled type 2 diabetes presents with altered mental status, Kussmaul respirations, and fruity breath. Labs show glucose of 650 mg/dL, pH of 7.20, and potassium of 2.9 mEq/L. Which mechanism best explains his hypokalemia?</span></span></p>",
    "unique_key": "Q3415789",
    "question_audio": null,
    "question_video": null,
    "map_id": 25358,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Shift of potassium into cells in exchange for hydrogen ions.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">DKA causes urinary potassium loss and a shift of potassium into cells to buffer acidosis. This initial exchange can lead to a temporary rise in potassium, but overall potassium stores are depleted.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Increased urinary potassium excretion due to glycosuria:</span></strong><span style=\"font-size:12.0pt\">&nbsp;While glycosuria (glucose in the urine) can contribute to potassium loss, it is not the primary mechanism in DKA. The exchange mechanism with hydrogen ions plays a more significant role.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Vomiting-induced potassium loss:</span></strong><span style=\"font-size:12.0pt\">&nbsp;Vomiting can cause hypokalemia, but it is not the dominant factor in DKA, where the underlying metabolic derangements are more critical.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Insulin deficiency-induced intracellular shift of potassium:</span></strong><span style=\"font-size:12.0pt\">&nbsp;Insulin deficiency does initially cause potassium to shift out of cells, leading to a temporary increase in serum potassium. However, this is followed by the exchange with hydrogen ions, resulting in overall potassium depletion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand the complex mechanisms of hypokalemia in diabetic ketoacidosis (DKA). It is important to recognize that the initial hyperkalemia is transient, and the overall effect is total body potassium depletion due to the shift of potassium into cells to buffer acidosis and urinary potassium loss through glycosuria. This understanding is crucial for appropriate management of DKA, which includes potassium replacement along with insulin and fluid therapy.</span></span></span></p>",
    "correct_choice_id": 214500,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 53757,
    "choices": [
      {
        "id": 214501,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gitelman syndrome </span></span></span></p>"
      },
      {
        "id": 214502,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Primary hyperaldosteronism </span></span></span></p>"
      },
      {
        "id": 214503,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Renal tubular acidosis (RTA) </span></span></span></p>"
      },
      {
        "id": 214504,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Diuretic use</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman presents with muscle cramps and weakness. Her serum potassium is 2.5 mEq/L. She has been taking furosemide for hypertension and reports frequent watery diarrhea. Her blood pressure is 110/70 mmHg. What is the most likely cause of her hypokalemia?</span></span></p>",
    "unique_key": "Q7163260",
    "question_audio": null,
    "question_video": null,
    "map_id": 25359,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Diuretic use</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s history of furosemide use, a loop diuretic, and diarrhea (extrarenal loss) explains the hypokalemia. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Gitelman syndrome:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This is a genetic disorder causing hypokalemia, but it typically presents with milder hypokalemia and often involves low urine calcium excretion, which is not mentioned in the case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Primary hyperaldosteronism:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This condition can cause hypokalemia due to increased potassium excretion, but it usually leads to high blood pressure, which is not present in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Renal tubular acidosis (RTA):</span></strong><span style=\"font-size:12.0pt\">&nbsp;RTA can also cause hypokalemia, but it often presents with metabolic acidosis, which is not mentioned in the case. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To identify diuretic use as the most common cause of hypokalemia in patients presenting with muscle cramps and weakness, especially in those with a history of diuretic therapy and additional sources of potassium loss like diarrhea.</span></span></span></p>",
    "correct_choice_id": 214504,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 53758,
    "choices": [
      {
        "id": 214505,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Renal tubular acidosis </span></span></span></p>"
      },
      {
        "id": 214506,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Primary hyperaldosteronism </span></span></span></p>"
      },
      {
        "id": 214507,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gastrointestinal losses </span></span></span></p>"
      },
      {
        "id": 214508,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Diuretic use</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old woman with a history of Crohn&#39;s disease and chronic diarrhea presents with fatigue and muscle cramps. Laboratory tests reveal a serum potassium of 3.0 mEq/L and metabolic alkalosis. Which of the following is the most likely mechanism of her hypokalemia?</span></span></p>",
    "unique_key": "Q7098892",
    "question_audio": null,
    "question_video": null,
    "map_id": 25360,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Gastrointestinal losses</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chronic diarrhea in Crohn&#39;s disease can lead to significant potassium loss through the GI tract, resulting in hypokalemia and metabolic alkalosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Renal tubular acidosis</span></strong><span style=\"font-size:12.0pt\">: Renal tubular acidosis typically presents with metabolic acidosis and hyperkalemia,&nbsp;not alkalosis and hypokalemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span style=\"font-size:12.0pt\">B. Primary hyperaldosteronism</span></strong><span style=\"font-size:12.0pt\">: Primary hyperaldosteronism causes hypokalemia but not metabolic alkalosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Diuretic use</span></strong><span style=\"font-size:12.0pt\">: Diuretic use is not mentioned in the patient&#39;s history</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize the association between chronic diarrhea in Crohn&#39;s disease and hypokalemia with metabolic alkalosis. Gastrointestinal losses of potassium and bicarbonate can lead to this electrolyte imbalance.</span></span></span></p>",
    "correct_choice_id": 214507,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 53759,
    "choices": [
      {
        "id": 214509,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypokalemic periodic paralysis </span></span></span></p>"
      },
      {
        "id": 214510,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Exertional rhabdomyolysis </span></span></span></p>"
      },
      {
        "id": 214511,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Heat stroke </span></span></span></p>"
      },
      {
        "id": 214512,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hyponatremia</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old athlete presents with sudden-onset muscle paralysis after completing a marathon. He has been consuming large amounts of water during the race. His blood pressure is normal, and he is afebrile. Which of the following is the most likely diagnosis?</span></span></p>",
    "unique_key": "Q3154809",
    "question_audio": null,
    "question_video": null,
    "map_id": 25361,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Hypokalemic periodic paralysis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypokalemic periodic paralysis is characterized by episodes of muscle weakness or paralysis, often triggered by strenuous exercise, high carbohydrate meals, or stress. The athlete&#39;s history of excessive water intake during the marathon may have further exacerbated the hypokalemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Exertional rhabdomyolysis:</span></strong><span style=\"font-size:12.0pt\">&nbsp;While marathon running can cause rhabdomyolysis,&nbsp;this would usually present with muscle pain,&nbsp;weakness,&nbsp;and dark urine,&nbsp;rather than sudden paralysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Heat stroke:</span></strong><span style=\"font-size:12.0pt\">&nbsp;Heat stroke would likely cause hyperthermia and altered mental status,&nbsp;neither of which is mentioned in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hyponatremia:</span></strong><span style=\"font-size:12.0pt\">&nbsp;Excessive water intake during a marathon can cause hyponatremia,&nbsp;which can also lead to neurological symptoms,&nbsp;but sudden paralysis is more characteristic of hypokalemic periodic paralysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand that hypokalemic periodic paralysis can present with sudden-onset muscle paralysis, often triggered by strenuous exercise and excessive water intake. This condition should be considered in athletes experiencing such symptoms after intense physical activity.</span></span></span></p>",
    "correct_choice_id": 214509,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 53760,
    "choices": [
      {
        "id": 214513,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">10 mL </span></span></span></p>"
      },
      {
        "id": 214514,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">20 mL </span></span></span></p>"
      },
      {
        "id": 214515,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">40 mL </span></span></span></p>"
      },
      {
        "id": 214516,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">80 mL</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">You are preparing to administer potassium chloride (KCl) to a patient with hypokalemia. The physician has ordered 40 mEq of KCl, and the available solution concentration is 2 mEq/mL. How many milliliters of KCl should you draw up in the syringe?</span></span></p>",
    "unique_key": "Q5811273",
    "question_audio": null,
    "question_video": null,
    "map_id": 25362,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) 20 mL</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To calculate the volume needed, you can use the following formula:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Volume (mL) = Dose (mEq) / Concentration (mEq/mL)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In this case: Volume (mL) = 40 mEq / 2 mEq/mL = 20 mL</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Therefore, you should draw up 20 mL of the KCl solution in the syringe</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To understand the calculation of medication dosage and volume based on the desired dose and concentration of the solution. In this case, the formula Volume (mL) = Dose (mEq) / Concentration (mEq/mL) was used to determine the correct volume of potassium chloride (KCl) to administer.</span></span></span></p>",
    "correct_choice_id": 214514,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 53761,
    "choices": [
      {
        "id": 214517,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Hypernatremia </span></span></span></p>"
      },
      {
        "id": 214518,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Hypocalcemia </span></span></span></p>"
      },
      {
        "id": 214519,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Hypermagnesemia </span></span></span></p>"
      },
      {
        "id": 214520,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypomagnesemia</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old man with a history of chronic alcoholism and diuretic use is admitted to the hospital for community-acquired pneumonia. Laboratory results reveal a serum potassium level of 2.8 mEq/L and an ECG demonstrating flattened T waves and prominent U waves. What other electrolyte abnormality are you suspecting in this patient?</span></span></p>",
    "unique_key": "Q1229335",
    "question_audio": null,
    "question_video": null,
    "map_id": 25363,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Hypomagnesemia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Patients with chronic alcoholism are often malnourished and have multiple electrolyte disturbances. Hypomagnesemia is a common finding in alcoholics and can coexist with hypokalemia. Magnesium is a cofactor for potassium uptake into cells, and inadequate magnesium levels can hinder potassium repletion efforts. Therefore, correcting both hypokalemia and hypomagnesemia is crucial for optimal treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Hypernatremia:</span></strong><span style=\"font-size:12.0pt\">&nbsp;Hypernatremia (high sodium) is not typically associated with hypokalemia in this clinical scenario.&nbsp;Alcoholism is more often associated with hyponatremia (low sodium).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hypocalcemia:</span></strong><span style=\"font-size:12.0pt\">&nbsp;While hypocalcemia can occur in alcoholics,&nbsp;it is not directly related to hypokalemia and its correction is not necessary for effective potassium repletion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Hypermagnesemia:</span></strong><span style=\"font-size:12.0pt\">&nbsp;Hypermagnesemia (high magnesium) is rare and usually occurs in the setting of renal failure or excessive magnesium intake.&nbsp;It is not a common finding in alcoholism.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize the association between chronic alcoholism and hypomagnesemia, which often coexists with hypokalemia. Understanding this relationship is crucial for effective treatment, as magnesium repletion is often necessary for successful potassium replacement in these patients.</span></span></span></p>",
    "correct_choice_id": 214520,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 53911,
    "choices": [
      {
        "id": 215113,
        "text": "<p><span style=\"font-size:12.0pt;\">Anion gap metabolic acidosis</span></p>"
      },
      {
        "id": 215114,
        "text": "<p><span style=\"font-size:12.0pt;\">Anion gap metabolic acidosis plus metabolic alkalosis</span></p>"
      },
      {
        "id": 215115,
        "text": "<p><span style=\"font-size:12.0pt;\">Anion gap metabolic acidosis plus normal anion gap metabolic acidosis</span></p>"
      },
      {
        "id": 215116,
        "text": "<p><span style=\"font-size:12.0pt;\">Normal anion gap metabolic acidosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with the following laboratory values:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20130956.jpg\" width=\"652\" height=\"287\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Which of the following best describes the patient\u2019s acid\u2013base status?</span></p>",
    "unique_key": "Q5937760",
    "question_audio": null,
    "question_video": null,
    "map_id": 30797,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Anion gap metabolic acidosis plus normal anion gap metabolic acidosis</strong></span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option C:</strong>&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Anion Gap (AG): AG = Na \u2013 (Cl + HCO\u2083) = 138 \u2013 (112 + 8) = 18 (Normal ~12 \u2192 Elevated AG indicates anion gap metabolic acidosis.)</span></li><li><span style=\"font-size:12.0pt;\">Delta Gap (\u0394AG): \u0394AG = AG_actual \u2013 AG_normal = 18 \u2013 12 = 6</span></li><li><span style=\"font-size:12.0pt;\">Expected Drop in HCO\u2083 if Only AG Acidosis: ~6 mEq/L</span></li><li><span style=\"font-size:12.0pt;\">Actual Drop in HCO\u2083: 24 \u2013 8 = 16 mEq/L</span></li><li><span style=\"font-size:12.0pt;\">Delta\u2013Delta Ratio: (\u0394AG / \u0394HCO\u2083) = 6 / 16 \u2248 0.38 (&lt;1), indicating a second metabolic acidosis (normal anion gap) in addition to the high anion gap acidosis.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u>:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Anion gap metabolic acidosis:</strong> Does not account for the extra bicarbonate drop.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option B. Anion gap metabolic acidosis plus metabolic alkalosis:</strong> Would typically yield a higher bicarbonate, often with \u0394\u2013\u0394 &gt; 2.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option D. Normal anion gap metabolic acidosis:</strong> The elevated AG of 18 rules out a pure normal AG acidosis.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When you see a low bicarbonate and an elevated anion gap, use the Delta\u2013Delta Ratio. A ratio &lt;1 suggests coexisting anion gap and normal anion gap metabolic acidosis. Top of Form</span></p>",
    "correct_choice_id": 215115,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 53912,
    "choices": [
      {
        "id": 215117,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute respiratory acidosis</span></p>"
      },
      {
        "id": 215118,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute respiratory alkalosis</span></p>"
      },
      {
        "id": 215119,
        "text": "<p><span style=\"font-size:12.0pt;\">Chronic respiratory acidosis with metabolic compensation</span></p>"
      },
      {
        "id": 215120,
        "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis with respiratory compensation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient has the following laboratory findings:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131016.jpg\" width=\"706\" height=\"200\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Which of the following is the most likely acid\u2013base status</span></p>",
    "unique_key": "Q6531325",
    "question_audio": null,
    "question_video": null,
    "map_id": 30798,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Metabolic alkalosis with respiratory compensation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The pH is high (7.55), indicating alkalosis. The bicarbonate is significantly elevated (45 mEq/L), suggesting a primary metabolic alkalosis. In response, the body compensates by hypoventilating, thus increasing the PCO\u2082 to 53 mm Hg. A useful formula to estimate respiratory compensation in metabolic alkalosis is:</span></p><p><br><span style=\"font-size:12.0pt;\">Expected PaCO\u2082 (mm Hg) \u2248 0.7 \u00d7 [HCO\u2083\u207b] + 20 \u00b1 5</span></p><p><br><span style=\"font-size:12.0pt;\">Substituting 45 mEq/L for HCO\u2083\u207b gives (0.7 \u00d7 45) + 20 = 31.5 + 20 = 51.5 \u00b1 5 mm Hg. Because the actual PCO\u2082 (53 mm Hg) lies within that range, this confirms metabolic alkalosis with an appropriate respiratory (hypoventilatory) compensation</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u>:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Acute respiratory acidosis</strong> would present with a low pH (acidemia) and high PCO\u2082, not alkalemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Acute respiratory alkalosis</strong> would show a high pH but a low PCO\u2082.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Chronic respiratory acidosis</strong> with metabolic compensation typically results in a less elevated pH; 7.55 is too alkalotic for that scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A high bicarbonate and alkalemic pH accompanied by an elevated, appropriately compensated PCO\u2082 is characteristic of metabolic alkalosis with respiratory compensation.</span></p>",
    "correct_choice_id": 215120,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 53913,
    "choices": [
      {
        "id": 215121,
        "text": "<p><span style=\"font-size:12.0pt;\">Laboratory error in chloride measurement</span></p>"
      },
      {
        "id": 215122,
        "text": "<p><span style=\"font-size:12.0pt;\">Hypoalbuminemia leading to a reduction in the anion gap</span></p>"
      },
      {
        "id": 215123,
        "text": "<p><span style=\"font-size:12.0pt;\">Unmeasured cation excess due to multiple myeloma</span></p>"
      },
      {
        "id": 215124,
        "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 68-year-old man with chronic liver disease is admitted for worsening abdominal distension. His laboratory findings are as follows:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Sodium (Na\u207a): 140 mEq/L</span></li><li><span style=\"font-size:12.0pt;\">Chloride (Cl\u207b): 115 mEq/L</span></li><li><span style=\"font-size:12.0pt;\">Bicarbonate (HCO\u2083\u207b): 26 mEq/L</span></li><li><span style=\"font-size:12.0pt;\">Albumin: 1.2 g/dL</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Which of the following best explains the anion gap?</span></p>",
    "unique_key": "Q3069889",
    "question_audio": null,
    "question_video": null,
    "map_id": 30799,
    "difficulty_level": "difficult",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Hypoalbuminemia leading to a reduction in the anion gap</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The anion gap is calculated as:</span><br><span style=\"font-size:12.0pt;\">Anion&nbsp;Gap&nbsp;(AG)=Na\u207a\u2212(Cl\u207b+HCO\u2083\u207b)&nbsp;</span><br><span style=\"font-size:12.0pt;\">AG=140\u2212(115+26)=140\u2212141=\u22121\u2009mEq/L</span><br><span style=\"font-size:12.0pt;\">In this patient, the anion gap is near zero, which is abnormally low. Albumin, a major unmeasured anion, contributes significantly to the anion gap. For every 1 g/dL decrease in serum albumin (normal ~4 g/dL), the anion gap decreases by approximately 2.5 mEq/L.</span></p><p><br><span style=\"font-size:12.0pt;\">With this patient's albumin of 1.2 g/dL, the anion gap is reduced by:</span><br><span style=\"font-size:12.0pt;\">Reduction&nbsp;in&nbsp;AG=(4\u22121.2)\u00d72.5=7\u2009mEq/L&nbsp;</span><br><span style=\"font-size:12.0pt;\">The expected corrected anion gap would be approximately 6\u20138 mEq/L (within the low-normal range after accounting for hypoalbuminemia). Therefore, the low anion gap is adequately explained by hypoalbuminemia in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u>:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Laboratory error in chloride measurement</strong> is unlikely because the sodium, chloride, and bicarbonate levels are consistent with normal measurement trends.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option C. Unmeasured cation excess due to multiple myeloma</strong> can reduce the anion gap through excess cationic monoclonal proteins, but this patient has no evidence of multiple myeloma, and hypoalbuminemia is a more likely explanation.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option D. Metabolic alkalosis</strong> does not typically result in a low anion gap. It may raise bicarbonate, but that does not account for the reduction in the anion gap observed here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><br><span style=\"font-size:12.0pt;\">The anion gap is significantly influenced by albumin levels. Hypoalbuminemia decreases the anion gap by reducing unmeasured anions. In this case, the corrected anion gap appropriately accounts for the low albumin, ruling out other causes.</span></p>",
    "correct_choice_id": 215122,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 53915,
    "choices": [
      {
        "id": 215129,
        "text": "<p><span style=\"font-size:12.0pt;\">Excessive administration of normal saline</span></p>"
      },
      {
        "id": 215130,
        "text": "<p><span style=\"font-size:12.0pt;\">Ketone body production</span></p>"
      },
      {
        "id": 215131,
        "text": "<p><span style=\"font-size:12.0pt;\">Hyperchloremia</span></p>"
      },
      {
        "id": 215132,
        "text": "<p><span style=\"font-size:12.0pt;\">Accumulation of lactate</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old diabetic patient presents with fever and altered mental status. On examination, his blood pressure is 70/40 mm Hg and his pulse rate is 134/min. He has crackles over the left infrascapular region. Lab results are as follows: Na\u207a: 138 mEq/L, Cl\u207b: 98 mEq/L, HCO\u2083\u207b: 10 mEq/L, BUN: 58 mg/dL, Creatinine: 3.0 mg/dL, Blood glucose: 180 mg/dL. Which of the following best explains the anion gap?</span></p>",
    "unique_key": "Q4467870",
    "question_audio": null,
    "question_video": null,
    "map_id": 30800,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Accumulation of lactate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The anion gap (AG) = Na \u2212 (Cl + HCO\u2083) = 138 \u2212 (98 + 10) = 30, which is markedly elevated. The patient\u2019s hypotension and fever suggest septic shock, commonly causing lactic acidosis due to tissue hypoperfusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u>:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Excessive administration of normal saline:</strong> Causes a normal anion gap (hyperchloremic) acidosis, not an elevated one.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option B. Ketone body production:</strong> Are less likely because the glucose of 180 mg/dL is not highly suggestive of diabetic ketoacidosis, and the clinical picture points more toward sepsis.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option C. Hyperchloremia:</strong> Results in Normal Anion Gap Metabolic Acidosis</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><br><span style=\"font-size:12.0pt;\">In a hypotensive, septic patient, a high anion gap metabolic acidosis most often indicates lactic acidosis secondary to poor tissue perfusion.</span></p>",
    "correct_choice_id": 215132,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 53916,
    "choices": [
      {
        "id": 215133,
        "text": "<p><span style=\"font-size:12.0pt;\">Excess NH\u2084\u207a excretion</span></p>"
      },
      {
        "id": 215134,
        "text": "<p><span style=\"font-size:12.0pt;\">Low NH\u2084\u207a excretion</span></p>"
      },
      {
        "id": 215135,
        "text": "<p><span style=\"font-size:12.0pt;\">High Urinary Chloride</span></p>"
      },
      {
        "id": 215136,
        "text": "<p><span style=\"font-size:12.0pt;\">Excessive urinary acidification</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old man with hypokalemia and recurrent kidney stones presents with normal anion gap metabolic acidosis. His urinary anion gap is measured and found to be positive. Which of the following best explains this finding?</span></p>",
    "unique_key": "Q3066366",
    "question_audio": null,
    "question_video": null,
    "map_id": 30801,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Low NH\u2084\u207a excretion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The urinary anion gap (Na\u207a + K\u207a \u2013 Cl\u207b) is used to estimate urinary ammonium (NH\u2084\u207a) excretion in normal anion gap metabolic acidosis. A <strong>positive</strong> urinary anion gap suggests <strong>inadequate (low) NH\u2084\u207a excretion</strong>, indicating a renal acidification defect, such as distal renal tubular acidosis (RTA). Hypokalemia and recurrent kidney stones further support a renal cause of the acidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Excess NH\u2084\u207a excretion</strong>: Would cause a <strong>negative</strong> urinary anion gap, more typical of GI bicarbonate loss rather than a renal defect.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option C. High urinary chloride:</strong> Alone does not necessarily produce a <strong>positive</strong> urinary anion gap; in fact, increased urinary chloride often makes the gap more negative or closer to zero.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option D. Excessive urinary acidification</strong>: Is not consistent with a <strong>positive</strong> urinary anion gap; with adequate NH\u2084\u207a excretion and acidification, the gap would be negative.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><br><span style=\"font-size:12.0pt;\">A <strong>positive</strong> urinary anion gap in a patient with normal anion gap metabolic acidosis typically indicates <strong>low NH\u2084\u207a excretion</strong> and points to a <strong>renal</strong> rather than <strong>GI</strong> cause of the acidosis (e.g., distal RTA).</span></p>",
    "correct_choice_id": 215134,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 53918,
    "choices": [
      {
        "id": 215141,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute metabolic acidosis</span></p>"
      },
      {
        "id": 215142,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute respiratory acidosis</span></p>"
      },
      {
        "id": 215143,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute respiratory acidosis plus acute metabolic acidosis</span></p>"
      },
      {
        "id": 215144,
        "text": "<p><span style=\"font-size:12.0pt;\">Chronic respiratory acidosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient has the following laboratory findings:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131110.jpg\" width=\"874\" height=\"296\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Which of the following is the most likely acid-base status?</span></p>",
    "unique_key": "Q8982059",
    "question_audio": null,
    "question_video": null,
    "map_id": 30802,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Chronic respiratory acidosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The <strong>low pH (7.34)</strong> indicates acidemia. The elevated <strong>PCO\u2082 (60 mmHg)</strong> suggests a <strong>respiratory acidosis</strong>, and the elevated <strong>bicarbonate (31 mEq/L)</strong> reflects <strong>renal compensation</strong>, which occurs only in chronic conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Compensation for Chronic Respiratory Acidosis:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Change in PaCO\u2082:</strong></span><br><span style=\"font-size:12.0pt;\">Observed PaCO\u2082 = 60 mmHg</span><br><span style=\"font-size:12.0pt;\">Normal PaCO\u2082 = 40 mmHg</span><br><span style=\"font-size:12.0pt;\">Change in PaCO\u2082 = 60 - 40 = 20 mmHg</span></li><li><span style=\"font-size:12.0pt;\"><strong>Bicarbonate Compensation:</strong></span><br><span style=\"font-size:12.0pt;\">For chronic respiratory acidosis, bicarbonate increases by <strong>4 mEq/L</strong> for every <strong>10 mmHg</strong> rise in PaCO\u2082.</span><br><span style=\"font-size:12.0pt;\">Calculation: 20/10\u00d74=8\u2009mEq/L</span></li><li><span style=\"font-size:12.0pt;\"><strong>Expected Bicarbonate Level:</strong></span><br><span style=\"font-size:12.0pt;\">Normal bicarbonate = 24 mEq/L</span><br><span style=\"font-size:12.0pt;\">Expected bicarbonate = 24 + 8 = <strong>32 mEq/L</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Conclusion:</strong></span><br><span style=\"font-size:12.0pt;\">The observed bicarbonate level (<strong>31 mEq/L</strong>) is close to the expected value (<strong>32 mEq/L</strong>), confirming <strong>chronic respiratory acidosis with renal compensation</strong>.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This confirms <strong>chronic respiratory acidosis with renal compensation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u>:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Acute metabolic acidosis</strong>: Incorrect because metabolic acidosis would present with a low bicarbonate and compensatory low PCO\u2082, not elevated PCO\u2082.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option B. Acute respiratory acidosis</strong>: Incorrect because bicarbonate is elevated, indicating renal compensation, which occurs only in chronic conditions.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option C. Acute respiratory acidosis plus acute metabolic acidosis</strong>: Incorrect because the elevated bicarbonate rules out a primary metabolic acidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic respiratory acidosis occurs with prolonged CO\u2082 retention, leading to renal compensation by increasing bicarbonate. Differentiating acute from chronic respiratory acidosis requires assessing bicarbonate levels, which increase significantly only in chronic conditions.</span></p>",
    "correct_choice_id": 215144,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 53919,
    "choices": [
      {
        "id": 215145,
        "text": "<p><span style=\"font-size:12.0pt;\">Anion gap metabolic acidosis</span></p>"
      },
      {
        "id": 215146,
        "text": "<p><span style=\"font-size:12.0pt;\">Anion gap metabolic acidosis plus metabolic alkalosis</span></p>"
      },
      {
        "id": 215147,
        "text": "<p><span style=\"font-size:12.0pt;\">Anion gap metabolic acidosis plus normal anion gap metabolic acidosis</span></p>"
      },
      {
        "id": 215148,
        "text": "<p><span style=\"font-size:12.0pt;\">Normal anion gap metabolic acidosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient has the following laboratory findings:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131127.jpg\" width=\"773\" height=\"323\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Which of the following is the most likely acid-base status?</span></p>",
    "unique_key": "Q9378010",
    "question_audio": null,
    "question_video": null,
    "map_id": 30803,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Anion gap metabolic acidosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient has a pH of 7.23, indicating acidemia. The PCO\u2082 of 25 mmHg is appropriately reduced, consistent with respiratory compensation for metabolic acidosis. The anion gap (AG) is calculated as AG = Na\u207a - (Cl\u207b + HCO\u2083\u207b) = 138 - (100 + 10) = 28, indicating an anion gap metabolic acidosis (normal &lt;12). Using the delta ratio helps confirm the presence of a pure anion gap acidosis: \u0394AG = measured AG - normal AG = 28 - 12 = 16, and \u0394HCO\u2083\u207b = normal HCO\u2083\u207b - measured HCO\u2083\u207b = 24 - 10 = 14. The delta ratio (\u0394AG/\u0394HCO\u2083\u207b) = 16/14 = 1.14, which is within the expected range (1\u20132) for a pure anion gap metabolic acidosis. There is no evidence of an additional metabolic alkalosis or normal anion gap metabolic acidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u>:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Anion gap metabolic acidosis</strong>: Plus metabolic alkalosis is incorrect because there is no elevated bicarbonate or evidence of alkalosis.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Anion gap metabolic acidosis plus normal anion gap metabolic acidosis:</strong> Is incorrect as there is no hyperchloremia to suggest an additional non-anion gap acidosis.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Normal anion gap metabolic acidosis</strong>: Is incorrect as the elevated anion gap clearly indicates an anion gap metabolic acidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Delta-delta ratio analysis helps differentiate pure anion gap metabolic acidosis from mixed acid-base disorders. A ratio within the normal range (1\u20132) confirms a single anion gap metabolic acidosis without additional acid-base disturbances.</span></p>",
    "correct_choice_id": 215145,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 53920,
    "choices": [
      {
        "id": 215149,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute respiratory acidosis</span></p>"
      },
      {
        "id": 215150,
        "text": "<p><span style=\"font-size:12.0pt;\">Chronic respiratory acidosis</span></p>"
      },
      {
        "id": 215151,
        "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis plus primary respiratory alkalosis</span></p>"
      },
      {
        "id": 215152,
        "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis with appropriate respiratory compensation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient has the following laboratory findings:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131148.jpg\" width=\"783\" height=\"237\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Which of the following is the most likely acid-base status?</span></p>",
    "unique_key": "Q8362815",
    "question_audio": null,
    "question_video": null,
    "map_id": 30786,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Metabolic acidosis plus primary respiratory alkalosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The pH of 7.36 indicates <strong>compensated acidemia</strong>. The low bicarbonate (13 mEq/L) suggests <strong>primary metabolic acidosis</strong>, while the low PCO\u2082 (24 mmHg) indicates a <strong>coexisting respiratory alkalosis</strong> beyond expected compensation. Using <strong>Winter\u2019s formula</strong>, the expected PCO\u2082 for pure metabolic acidosis is calculated as:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Expected PCO\u2082 = (1.5 \u00d7 HCO\u2083\u207b) + 8 \u00b1 2</span><br><span style=\"font-size:12.0pt;\">Expected PCO\u2082 = (1.5 \u00d7 13) + 8 \u00b1 2 = 27.5 \u00b1 2 (range: 25.5\u201329.5)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The measured PCO\u2082 of 24 mmHg is <strong>lower than expected</strong>, indicating a <strong>primary respiratory alkalosis</strong> in addition to the metabolic acidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u>:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Acute respiratory acidosis</strong>: Is incorrect because the PCO\u2082 is low, not elevated, ruling out respiratory acidosis.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option B. Chronic respiratory acidosis</strong>: Is incorrect because the bicarbonate would be elevated due to renal compensation, not reduced.</span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Metabolic acidosis with appropriate respiratory compensation</strong>: Is incorrect because the PCO\u2082 is lower than the expected range, indicating an additional primary respiratory alkalosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The delta ratio and Winter\u2019s formula are essential tools for evaluating mixed acid-base disorders. A PCO\u2082 lower than expected in metabolic acidosis suggests an additional respiratory alkalosis. This highlights the importance of calculating expected compensation to detect hidden mixed disorders.</span></p>",
    "correct_choice_id": 215151,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 53921,
    "choices": [
      {
        "id": 215153,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute metabolic acidosis</span></p>"
      },
      {
        "id": 215154,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute respiratory acidosis</span></p>"
      },
      {
        "id": 215155,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute respiratory acidosis plus acute metabolic acidosis</span></p>"
      },
      {
        "id": 215156,
        "text": "<p><span style=\"font-size:12.0pt;\">Chronic metabolic acidosis with respiratory compensation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient has the following laboratory findings:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131209.jpg\" width=\"706\" height=\"243\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Which of the following is the most likely acid-base status?</span></p>",
    "unique_key": "Q3420328",
    "question_audio": null,
    "question_video": null,
    "map_id": 30787,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Acute respiratory acidosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The pH of <strong>7.27</strong> indicates acidemia. The <strong>elevated PCO\u2082 (55 mmHg)</strong> suggests a primary respiratory cause (respiratory acidosis). The <strong>normal bicarbonate (25 mEq/L)</strong> indicates there hasn\u2019t been enough time for renal compensation, which would elevate bicarbonate levels in a chronic process.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Using the compensation formula for acute respiratory acidosis:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">\u0394pH = 0.008 \u00d7 \u0394PaCO\u2082</span></p><p><br><span style=\"font-size:12.0pt;\">\u0394PaCO\u2082 = 55 \u2212 40 = 15</span></p><p><br><span style=\"font-size:12.0pt;\">\u0394pH = 0.008 \u00d7 15 = 0.12</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Expected pH = 7.40 \u2212 0.12 = 7.28.</span></p><p><br><span style=\"font-size:12.0pt;\">The measured pH of 7.27 closely matches the expected value, confirming <strong>acute respiratory acidosis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u>:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Acute metabolic acidosis</strong>: Incorrect because metabolic acidosis would present with low bicarbonate and compensatory low PCO\u2082, which are not observed here.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option C. Acute respiratory acidosis plus acute metabolic acidosis</strong>: Incorrect because the bicarbonate is normal, ruling out metabolic acidosis.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option D. Chronic metabolic acidosis with respiratory compensation</strong>: Incorrect because chronic metabolic acidosis would present with low bicarbonate and low PCO\u2082 as compensation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acute respiratory acidosis is characterized by an acidemic pH, elevated PCO\u2082, and normal bicarbonate (before compensation occurs). Compensation for respiratory acidosis takes days, so normal bicarbonate suggests an acute process.</span></p>",
    "correct_choice_id": 215154,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 53922,
    "choices": [
      {
        "id": 215157,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute metabolic acidosis</span></p>"
      },
      {
        "id": 215158,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute respiratory alkalosis</span></p>"
      },
      {
        "id": 215159,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute respiratory alkalosis plus acute metabolic alkalosis</span></p>"
      },
      {
        "id": 215160,
        "text": "<p><span style=\"font-size:12.0pt;\">Chronic respiratory alkalosis with metabolic compensation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient has the following laboratory findings:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131229.jpg\" width=\"635\" height=\"224\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Which of the following is the most likely acid-base status?</span></p>",
    "unique_key": "Q5896669",
    "question_audio": null,
    "question_video": null,
    "map_id": 30788,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Chronic respiratory alkalosis with metabolic compensation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The pH of <strong>7.44</strong> is alkalotic, suggesting a primary alkalosis. The low <strong>PCO\u2082 (20 mmHg)</strong> indicates a <strong>respiratory cause</strong>. The low <strong>bicarbonate (13 mEq/L)</strong> reflects <strong>renal compensation</strong>, which occurs over time in chronic respiratory alkalosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Using the provided table:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">In <strong>chronic respiratory alkalosis</strong>, for every 10 mmHg decrease in PCO\u2082 below 40 mmHg, bicarbonate decreases by <strong>5 mEq/L</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Expected bicarbonate = 24 \u2212 [(40 \u2212 20)/10 \u00d7 5] = 24 \u2212 10 = <strong>14 mEq/L</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient\u2019s measured bicarbonate of <strong>13 mEq/L</strong> is consistent with expected compensation, confirming <strong>chronic respiratory alkalosis with metabolic compensation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u>:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Acute metabolic acidosis</strong>: Incorrect, as acidosis would result in a low pH, not the alkalotic pH seen here.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option B. Acute respiratory alkalosis</strong>: Incorrect because bicarbonate levels are reduced, indicating renal compensation, which occurs only in chronic conditions.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option C. Acute respiratory alkalosis plus acute metabolic alkalosis</strong>: Incorrect because the bicarbonate is low, ruling out metabolic alkalosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic respiratory alkalosis occurs with prolonged hyperventilation, leading to renal compensation by reducing bicarbonate levels. The distinction between acute and chronic respiratory alkalosis is based on bicarbonate levels, which decrease significantly only in chronic conditions.</span></p>",
    "correct_choice_id": 215160,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 53923,
    "choices": [
      {
        "id": 215161,
        "text": "<p><span style=\"font-size:12.0pt;\">Anion gap metabolic acidosis</span></p>"
      },
      {
        "id": 215162,
        "text": "<p><span style=\"font-size:12.0pt;\">Anion gap metabolic acidosis plus metabolic alkalosis</span></p>"
      },
      {
        "id": 215163,
        "text": "<p><span style=\"font-size:12.0pt;\">Anion gap metabolic acidosis plus normal anion gap metabolic acidosis</span></p>"
      },
      {
        "id": 215164,
        "text": "<p><span style=\"font-size:12.0pt;\">Normal anion gap metabolic acidosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient has the following laboratory findings:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131245.jpg\" width=\"756\" height=\"268\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Which of the following is the most likely acid-base status?</span></p>",
    "unique_key": "Q1105406",
    "question_audio": null,
    "question_video": null,
    "map_id": 30789,
    "difficulty_level": "difficult",
    "subjects_id": [
      11
    ],
    "solution": "<p><strong>Ans. B) Anion gap metabolic acidosis plus metabolic alkalosis</strong></p><p>&nbsp;</p><p><strong>Option B:</strong></p><p>&nbsp;</p><p>Calculate the anion gap: AG = Na - (Cl + HCO\u2083\u207b) = 140 - (88 + 12) = 40. The anion gap is significantly elevated, indicating anion gap metabolic acidosis (AGMA).</p><p><strong>For the delta ratio:</strong></p><p>&nbsp;</p><p>\u0394AG = Measured AG - Normal AG = 40 - 12 = 28</p><p>\u0394HCO\u2083\u207b = Normal HCO\u2083\u207b - Measured HCO\u2083\u207b = 24 - 12 = 12</p><p>\u0394 Ratio = \u0394AG / \u0394HCO\u2083\u207b = 28 / 12 = 2.33</p><p>&nbsp;</p><p>A delta ratio &gt; 2 suggests the presence of concurrent metabolic alkalosis with the anion gap metabolic acidosis.</p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p><strong>Option A</strong>. Anion gap metabolic acidosis: This is partially correct but incomplete as it doesn't account for the mixed disorder indicated by the delta ratio &gt; 2.</p><p>&nbsp;</p><p><strong>Option C</strong>. Anion gap metabolic acidosis plus normal anion gap metabolic acidosis: Incorrect because the delta ratio &gt; 2 indicates alkalosis, not a second acidosis. In mixed normal gap and high gap acidosis, the delta ratio would be &lt; 1.</p><p>&nbsp;</p><p><strong>Option D</strong>. Normal anion gap metabolic acidosis: Clearly incorrect as the AG is significantly elevated at 40.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>Use the delta ratio to identify mixed acid-base disorders. A delta ratio &gt; 2 suggests concurrent metabolic alkalosis along with anion gap metabolic acidosis, which can occur in conditions like diabetic ketoacidosis with vomiting or lactic acidosis with diuretic use.</p>",
    "correct_choice_id": 215162,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 53924,
    "choices": [
      {
        "id": 215165,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute respiratory acidosis</span></p>"
      },
      {
        "id": 215166,
        "text": "<p><span style=\"font-size:12.0pt;\">Chronic respiratory acidosis</span></p>"
      },
      {
        "id": 215167,
        "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis with appropriate respiratory compensation</span></p>"
      },
      {
        "id": 215168,
        "text": "<p><span style=\"font-size:12.0pt;\">Mixed metabolic acidosis and respiratory acidosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient has the following laboratory findings:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131304.jpg\" width=\"832\" height=\"238\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Which of the following is the most likely acid-base status?</span></p>",
    "unique_key": "Q2344773",
    "question_audio": null,
    "question_video": null,
    "map_id": 30790,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Mixed metabolic acidosis and respiratory acidosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Winter's formula predicts the expected PCO\u2082 for primary metabolic acidosis:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Expected PCO\u2082 = (1.5 \u00d7 HCO\u2083\u207b) + 8 \u00b1 2</span></p><p><br><span style=\"font-size:12.0pt;\">= (1.5 \u00d7 14) + 8 \u00b1 2</span></p><p><br><span style=\"font-size:12.0pt;\">= 21 \u00b1 2 mm Hg</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The observed PCO\u2082 is 35 mm Hg, which is significantly higher than the expected range (19\u201323 mm Hg). This indicates an additional respiratory acidosis on top of metabolic acidosis, confirming a mixed acid-base disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u>:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Acute respiratory acidosis:</strong> The low bicarbonate and pH indicate metabolic involvement, which excludes isolated acute respiratory acidosis.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option B. Chronic respiratory acidosis:</strong> Chronic conditions show higher bicarbonate compensation, which is not present here.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option C. Metabolic acidosis with appropriate respiratory compensation:</strong> The observed PCO\u2082 is much higher than predicted by Winter's formula, ruling out appropriate compensation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><br><span style=\"font-size:12.0pt;\">Winter's formula is a crucial tool to differentiate between simple and mixed acid-base disorders in metabolic acidosis. A discrepancy between observed and expected PCO\u2082 indicates an additional respiratory process.&nbsp;</span></p>",
    "correct_choice_id": 215168,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 53925,
    "choices": [
      {
        "id": 215169,
        "text": "<p><span style=\"font-size:12.0pt;\">Chronic respiratory alkalosis</span></p>"
      },
      {
        "id": 215170,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute respiratory alkalosis</span></p>"
      },
      {
        "id": 215171,
        "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis plus respiratory acidosis</span></p>"
      },
      {
        "id": 215172,
        "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis plus respiratory alkalosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient has the following laboratory findings:&nbsp;</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Bicarbonate (HCO\u2083\u207b): 32 mEq/L&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">pH: 7.51&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">PCO\u2082: 35 mm Hg</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Which of the following best describes the patient's acid-base status?</span></p>",
    "unique_key": "Q7713547",
    "question_audio": null,
    "question_video": null,
    "map_id": 30791,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Correct Answer: D. Metabolic alkalosis plus respiratory alkalosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The pH of 7.51 indicates alkalemia (alkalotic state).&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">The elevated bicarbonate (&gt;24 mEq/L) signifies a primary metabolic alkalosis.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">In metabolic alkalosis, the respiratory system typically compensates by increasing&nbsp;</span></li></ul><p><span style=\"font-size:12.0pt;\">PCO\u2082 to help normalize pH. But here the PCO\u2082 is 35 mm Hg (&lt;40), which is low indicating an independent respiratory alkalosis as well.&nbsp;</span></p><ul><li><span style=\"font-size:12.0pt;\">Whenever HCO\u2083\u207b (high in this case) and PCO2 (low in this case), move in opposite directions&nbsp; it is highly suggestive of a mixed disorder.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Option A. Chronic respiratory alkalosis</strong>: Usually presents with decreased PCO\u2082 and a compensatory decrease in bicarbonate (not elevated). The elevated bicarbonate here rules this out.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option B. Acute respiratory alkalosis</strong>: Typically involves decreased PCO\u2082 with normal bicarbonate and an elevated pH. Since bicarbonate is grossly elevated here, this does not fit.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. Metabolic alkalosis plus respiratory acidosis</strong>: Respiratory acidosis involves elevated PCO\u2082, but here PCO\u2082 is low, so this is incorrect.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When HCO\u2083\u207b and PCO\u2082 move in opposite directions\u2014it indicates a mixed acid-base disorder.</span></p>",
    "correct_choice_id": 215172,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 53926,
    "choices": [
      {
        "id": 215173,
        "text": "<p><span style=\"font-size:12.0pt;\">Methanol poisoning</span></p>"
      },
      {
        "id": 215174,
        "text": "<p><span style=\"font-size:12.0pt;\">Diabetic ketoacidosis</span></p>"
      },
      {
        "id": 215175,
        "text": "<p><span style=\"font-size:12.0pt;\">Lactic acidosis</span></p>"
      },
      {
        "id": 215176,
        "text": "<p><span style=\"font-size:12.0pt;\">Renal failure</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old man presents with severe metabolic acidosis and the following lab results:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Sodium: 140 mEq/L</span></li><li><span style=\"font-size:12.0pt;\">Chloride: 100 mEq/L</span></li><li><span style=\"font-size:12.0pt;\">Bicarbonate: 8 mEq/L</span></li><li><span style=\"font-size:12.0pt;\">BUN: 56 mg/dL</span></li><li><span style=\"font-size:12.0pt;\">Plasma Glucose: 180 mg/dL</span></li><li><span style=\"font-size:12.0pt;\">Serum Osmolality: 332 mOsm/kg</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Which of the following is the most likely cause of the metabolic acidosis?</span></p>",
    "unique_key": "Q4880284",
    "question_audio": null,
    "question_video": null,
    "map_id": 30792,
    "difficulty_level": "difficult",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Methanol poisoning</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">To determine the most likely cause of the metabolic acidosis, the serum osmolal gap and anion gap are calculated:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Serum osmolality (calculated):</strong></span><br><span style=\"font-size:12.0pt;\">Formula:</span></p><p><span style=\"font-size:12.0pt;\">Calculated&nbsp;Osmolality=(2\u00d7Na\u207a)+BUN2.8+Glucose18</span></p><p><span style=\"font-size:12.0pt;\">Substituting the values:</span></p><p><span style=\"font-size:12.0pt;\">(2\u00d7140)+562.8+18018=280+20+10=310\u2009mOsm/kg</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Osmolal gap:</strong></span></p><p><span style=\"font-size:12.0pt;\">Osmolal&nbsp;gap=Measured&nbsp;Osmolality\u2212Calculated&nbsp;Osmolality</span></p><p><span style=\"font-size:12.0pt;\"><strong>Substituting the values:</strong></span></p><p><span style=\"font-size:12.0pt;\">332\u2212310=22\u2009mOsm/kg</span></p><p><span style=\"font-size:12.0pt;\">An osmolal gap &gt;10 is significant and suggests the presence of unmeasured osmoles, often seen in toxic alcohol ingestion (e.g., methanol or ethylene glycol).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Anion gap:</strong></span><br><span style=\"font-size:12.0pt;\">Formula:</span></p><p><span style=\"font-size:12.0pt;\">Anion&nbsp;gap=Na\u207a\u2212(Cl\u207b+HCO\u2083\u207b)</span></p><p><span style=\"font-size:12.0pt;\">Substituting the values:</span></p><p><span style=\"font-size:12.0pt;\">140\u2212(100+8)=32\u2009mEq/L</span></p><p><span style=\"font-size:12.0pt;\">A high anion gap confirms metabolic acidosis.</span></p><p><span style=\"font-size:12.0pt;\">Given the high anion gap, elevated osmolal gap, and absence of hyperglycemia (ruling out DKA) or elevated lactate (ruling out lactic acidosis), methanol poisoning is the most likely cause.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u>:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Diabetic ketoacidosis:</strong> Typically presents with hyperglycemia &gt;250 mg/dL and does not cause an elevated osmolal gap.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option C. Lactic acidosis:</strong> Would present with elevated lactate levels, and would not present with elevated osmolal gap.&nbsp;</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option D. Renal failure:</strong> Causes a high anion gap metabolic acidosis due to retention of uremic toxins but does not cause an elevated osmolal gap.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><br><span style=\"font-size:12.0pt;\">In cases of high anion gap metabolic acidosis with an elevated osmolal gap, toxic alcohol ingestion (e.g., methanol or ethylene glycol) should be strongly suspected. Calculate both gaps to narrow the differential diagnosis.</span></p>",
    "correct_choice_id": 215173,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 53927,
    "choices": [
      {
        "id": 215177,
        "text": "<p><span style=\"font-size:12.0pt;\">Bartter syndrome</span></p>"
      },
      {
        "id": 215178,
        "text": "<p><span style=\"font-size:12.0pt;\">Gitelman syndrome</span></p>"
      },
      {
        "id": 215179,
        "text": "<p><span style=\"font-size:12.0pt;\">Vomiting</span></p>"
      },
      {
        "id": 215180,
        "text": "<p><span style=\"font-size:12.0pt;\">Primary aldosteronism</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old man presents with perioral tingling and paresthesias. His blood pressure is 100/60 mm Hg. His lab results are as follows:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Sodium: 142 mEq/L</span></li><li><span style=\"font-size:12.0pt;\">Chloride: 110 mEq/L</span></li><li><span style=\"font-size:12.0pt;\">Bicarbonate: 32 mEq/L</span></li><li><span style=\"font-size:12.0pt;\">Urinary chloride: 10 mEq/L</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">What is the most likely diagnosis?</span><br><br>&nbsp;</p>",
    "unique_key": "Q5247884",
    "question_audio": null,
    "question_video": null,
    "map_id": 30793,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Vomiting</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This patient presents with <strong>metabolic alkalosis</strong>, evidenced by elevated bicarbonate (32 mEq/L), and <strong>low urinary chloride</strong> (&lt; 20 mEq/L). This pattern strongly suggests <strong>chloride-responsive metabolic alkalosis</strong>, commonly caused by <strong>vomiting</strong> or nasogastric suction, which results in hydrochloric acid (HCl) loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The perioral tingling and paresthesias are likely due to <strong>hypocalcemia</strong>, caused by alkalosis. In metabolic alkalosis, hydrogen ions are buffered, leading to increased calcium binding to albumin and decreased ionized calcium levels, which trigger neuromuscular symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The low blood pressure (100/60 mm Hg) supports volume depletion due to fluid loss associated with vomiting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u>:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Bartter syndrome:&nbsp;</strong>Presents with metabolic alkalosis but is associated with high urinary chloride levels (&gt; 20 mEq/L) due to renal chloride wasting. Blood pressure is usually normal or low.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Gitelman syndrome:&nbsp;</strong>Also causes metabolic alkalosis with high urinary chloride levels (&gt; 20 mEq/L). It typically includes hypomagnesemia and hypocalciuria, which are not described here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Primary aldosteronism:&nbsp;</strong>Causes metabolic alkalosis with high urinary chloride levels (&gt; 20 mEq/L) and is associated with hypertension due to mineralocorticoid excess, which is inconsistent with this patient\u2019s low blood pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><br><span style=\"font-size:12.0pt;\">Metabolic alkalosis with <strong>low urinary chloride (&lt; 20 mEq/L)</strong> is a hallmark of <strong>chloride-responsive alkalosis</strong>, commonly caused by vomiting or diuretic use. Alkalosis-induced <strong>hypocalcemia</strong> can lead to symptoms like paresthesias and perioral tingling.</span></p>",
    "correct_choice_id": 215179,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 53928,
    "choices": [
      {
        "id": 215181,
        "text": "<p><span style=\"font-size:12.0pt;\">Proximal RTA</span></p>"
      },
      {
        "id": 215182,
        "text": "<p><span style=\"font-size:12.0pt;\">Distal RTA</span></p>"
      },
      {
        "id": 215183,
        "text": "<p><span style=\"font-size:12.0pt;\">Addison Disease</span></p>"
      },
      {
        "id": 215184,
        "text": "<p><span style=\"font-size:12.0pt;\">Enterocutaneous Fistula</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with severe weakness and a long-standing history of dry mouth and dry eyes. His lab results are as follows:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Serum Sodium (S. Na): 140 mEq/L</span></li><li><span style=\"font-size:12.0pt;\">Serum Potassium (S. K): 1.8 mEq/L</span></li><li><span style=\"font-size:12.0pt;\">Serum Chloride (S. Cl): 115 mEq/L</span></li><li><span style=\"font-size:12.0pt;\">Serum Bicarbonate (S. HCO\u2083): 12 mEq/L</span></li><li><span style=\"font-size:12.0pt;\">Urinary Sodium (Urinary Na): 25 mEq/L</span></li><li><span style=\"font-size:12.0pt;\">Urinary Potassium (Urinary K): 10 mEq/L</span></li><li><span style=\"font-size:12.0pt;\">Urinary Chloride (Urinary Cl): 20 mEq/L</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">What is the most likely cause of the patient\u2019s condition?</span><br><br>&nbsp;</p>",
    "unique_key": "Q9834212",
    "question_audio": null,
    "question_video": null,
    "map_id": 30794,
    "difficulty_level": "difficult",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B) Distal RTA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presents with severe hypokalemia (S. K = 1.8 mEq/L) and <strong>normal anion gap metabolic acidosis</strong> (low bicarbonate and hyperchloremia). Calculation of the <strong>urinary anion gap (UAG)</strong> further supports the diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The urinary anion gap is calculated as:</span></p><p><span style=\"font-size:12.0pt;\">UAG=(Urinary&nbsp;Na\u207a+Urinary&nbsp;K\u207a)\u2212Urinary&nbsp;Cl\u207b</span></p><p><span style=\"font-size:12.0pt;\">UAG=(25+10)\u221220=+15\u2009mEq/L</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A <strong>positive UAG</strong> suggests reduced ammonium (NH\u2084\u207a) excretion, which is characteristic of <strong>distal renal tubular acidosis (type 1 RTA)</strong>. This occurs because distal RTA involves an inability of the distal tubules to acidify urine, leading to impaired NH\u2084\u207a excretion and a positive UAG. The autoimmune symptoms (dry mouth, dry eyes) strongly suggest Sj\u00f6gren syndrome, a common cause of distal RTA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Causes of Positive and Negative UAG</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Positive UAG: </strong>Indicates impaired NH\u2084\u207a excretion, as seen in <strong>distal RTA</strong>, type 4 RTA (due to aldosterone deficiency or resistance).&nbsp;</span></li><li><span style=\"font-size:12.0pt;\"><strong>Negative UAG: </strong>Indicates intact renal acidification and high NH\u2084\u207a excretion, as seen in gastrointestinal bicarbonate loss (e.g., <strong>diarrhea</strong>, enterocutaneous fistulas) and proximal RTA.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u>:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Proximal RTA:</strong> Causes bicarbonate wasting and is associated with a negative UAG. Hypokalemia is usually milder.&nbsp;</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option C. Addison Disease:</strong> Leads to hyperkalemia due to aldosterone deficiency, which is inconsistent with the severe hypokalemia in this case.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option D. Enterocutaneous Fistula:</strong> Causes bicarbonate loss leading to metabolic acidosis but is associated with a <strong>negative UAG</strong> due to increased NH\u2084\u207a excretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><br><span style=\"font-size:12.0pt;\">A positive urinary anion gap in the context of normal anion gap metabolic acidosis indicates impaired renal ammonium excretion, a hallmark of <strong>distal RTA</strong>. This is a key differentiating feature from gastrointestinal bicarbonate losses, which present with a negative UAG. Recognizing these patterns helps narrow the differential diagnosis.</span></p>",
    "correct_choice_id": 215182,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 53929,
    "choices": [
      {
        "id": 215185,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute exacerbation of COPD</span></p>"
      },
      {
        "id": 215186,
        "text": "<p><span style=\"font-size:12.0pt;\">Chronic respiratory acidosis</span></p>"
      },
      {
        "id": 215187,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute respiratory acidosis</span></p>"
      },
      {
        "id": 215188,
        "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary embolism</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 61-year-old man presents with worsening fever, cough, and dyspnea for the past 2 days. He was started on empirical azithromycin 3 days ago, but his condition has worsened. ABG and lab results are as follows:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_aPTqPo5.png\" width=\"494\" height=\"641\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">What is the most likely diagnosis?</span></p>",
    "unique_key": "Q9892221",
    "question_audio": null,
    "question_video": null,
    "map_id": 30795,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Acute exacerbation of COPD</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This patient's presentation and ABG findings are consistent with <strong>acute exacerbation of COPD (AECOPD)</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>pH (7.27):</strong> Indicates acidemia.</span></li><li><span style=\"font-size:12.0pt;\"><strong>pCO\u2082 (59 mmHg):</strong> Elevated, pointing to respiratory acidosis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Bicarbonate (31 mEq/L):</strong> Elevated, consistent with chronic compensation in COPD.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The low pH, in the context of chronically compensated hypercapnia (as evidenced by elevated bicarbonate), suggests an acute respiratory acidosis due to AECOPD. The hypoxemia (pO\u2082 55 mmHg) further supports a decompensated state.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u>:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Chronic respiratory acidosis:</strong> Chronic respiratory acidosis is expected in stable COPD patients with compensated hypercapnia. However, the low pH in this patient indicates an acute decompensation.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option C. Acute respiratory acidosis:</strong> Pure acute respiratory acidosis would not explain the elevated bicarbonate, which reflects chronic compensation in COPD.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option D. Pulmonary embolism:</strong> Pulmonary embolism typically causes respiratory alkalosis due to hyperventilation, with low pCO\u2082 levels, not the hypercapnia seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><br><span style=\"font-size:12.0pt;\">In a patient with known COPD, a low pH with elevated pCO\u2082 and bicarbonate indicates acute respiratory acidosis superimposed on chronic compensation, suggesting <strong>acute exacerbation of COPD (AECOPD)</strong>. Prompt recognition and treatment of the underlying cause, such as infection, are critical.</span></p>",
    "correct_choice_id": 215185,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 53930,
    "choices": [
      {
        "id": 215189,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute respiratory distress syndrome (ARDS)</span></p>"
      },
      {
        "id": 215190,
        "text": "<p><span style=\"font-size:12.0pt;\">Type 1 respiratory failure</span></p>"
      },
      {
        "id": 215191,
        "text": "<p><span style=\"font-size:12.0pt;\">Alveolar hypoventilation</span></p>"
      },
      {
        "id": 215192,
        "text": "<p><span style=\"font-size:12.0pt;\">Type 4 respiratory failure</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 24-year-old pregnant woman (30 weeks gestation) has been diagnosed with pneumonia. She is currently receiving high-flow oxygen with an FiO\u2082 of 0.5. Her ABG and lab results are as follows:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">pH: 7.42</span></li><li><span style=\"font-size:12.0pt;\">pCO\u2082: 29 mmHg</span></li><li><span style=\"font-size:12.0pt;\">HCO\u2083\u207b: 20 mmol/L</span></li><li><span style=\"font-size:12.0pt;\">Base Excess: -5.1 mmol/L</span></li><li><span style=\"font-size:12.0pt;\">pO\u2082: 123 mmHg</span></li><li><span style=\"font-size:12.0pt;\">O\u2082 Saturation: 99%</span></li><li><span style=\"font-size:12.0pt;\">Potassium: 3.0 mmol/L</span></li><li><span style=\"font-size:12.0pt;\">Sodium: 133 mmol/L</span></li><li><span style=\"font-size:12.0pt;\">Chloride: 109 mmol/L</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">What is the most likely diagnosis?</span><br><br>&nbsp;</p>",
    "unique_key": "Q2402518",
    "question_audio": null,
    "question_video": null,
    "map_id": 30796,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Type 1 respiratory failure</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's hypoxemia (low pO\u2082) with a normal pCO\u2082 indicates Type 1 respiratory failure, which is commonly caused by V/Q mismatch. This is confirmed by calculating the A-a gradient:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>A-a gradient calculation:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>PAO\u2082 = FiO\u2082 \u00d7 (760 - 47) - (pCO\u2082 / 0.8)</strong></span></li><li><span style=\"font-size:12.0pt;\">PAO\u2082 = 0.5 \u00d7 (760 - 47) - (29 / 0.8)</span></li><li><span style=\"font-size:12.0pt;\">PAO\u2082 = 356.5 - 36.25 = 320.25 mmHg</span></li><li><span style=\"font-size:12.0pt;\">A-a gradient = PAO\u2082 - PaO\u2082 = 320.25 - 123 = <strong>197.25 mmHg</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">An A-a gradient &gt;30 mmHg is elevated and a response to O2 (Fio2 50%) is consistent with a V/Q mismatch. Pneumonia is a common cause of Type 1 respiratory failure due to alveolar filling impairing gas exchange.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u>:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong> <strong>Acute respiratory distress syndrome (ARDS):</strong> While ARDS can cause Type 1 respiratory failure, it typically presents with severe hypoxemia and bilateral infiltrates, and patients would not respond to 100% O2 due to significant shunting.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>Alveolar hypoventilation:</strong> This condition leads to hypercapnia (elevated pCO\u2082), which is not present in this patient.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Type 4 respiratory failure:</strong> Type 4 failure refers to hypoperfusion due to circulatory failure (e.g., septic shock), which is not indicated by the patient's ABG or clinical scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><br><span style=\"font-size:12.0pt;\">Type 1 respiratory failure is characterized by hypoxemia with a normal or low pCO\u2082 and is caused by V/Q mismatch, diffusion limitation, or shunting. An elevated A-a gradient with a good response to supplemental oxygen suggests V/Q mismatch, commonly seen in pneumonia.</span></p>",
    "correct_choice_id": 215190,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 53769,
    "choices": [
      {
        "id": 214549,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It measures BP every 15-30 minutes during the day and every 15-60 minutes at night. </span></span></span></p>"
      },
      {
        "id": 214550,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It provides a more comprehensive assessment of BP than isolated clinic readings. </span></span></span></p>"
      },
      {
        "id": 214551,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is less reliable than home BP monitoring for predicting target organ damage. </span></span></span></p>"
      },
      {
        "id": 214552,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">An attenuated nocturnal BP dip is associated with increased cardiovascular risk.</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements about ambulatory blood pressure monitoring (ABPM) is FALSE? </span></span></p>",
    "unique_key": "Q8734609",
    "question_audio": null,
    "question_video": null,
    "map_id": 25364,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) It is less reliable than home BP monitoring for predicting target organ damage. </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ABPM is considered more reliable than home BP monitoring in predicting target organ damage due to its comprehensive 24-hour assessment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. It measures BP every 15-30 minutes during the day and every 15-60 minutes at night</span></strong><span style=\"font-size:12.0pt\">: ABPM takes frequent BP readings throughout the day and night, providing a more complete picture than clinic readings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. It provides a more comprehensive assessment of BP than isolated clinic readings</span></strong><span style=\"font-size:12.0pt\">: ABPM captures BP variations throughout the day, unlike isolated clinic readings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. An attenuated nocturnal BP dip is associated with increased cardiovascular risk</span></strong><span style=\"font-size:12.0pt\">: Less pronounced or absent nocturnal BP dips are linked to higher cardiovascular risk. ABPM helps identify these patterns.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ABPM is a valuable tool for diagnosing and managing hypertension because it provides a more complete and accurate assessment of blood pressure patterns than other methods.</span></span></span></p>",
    "correct_choice_id": 214551,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 53770,
    "choices": [
      {
        "id": 214553,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ABPM (Ambulatory Blood Pressure Monitoring) </span></span></span></p>"
      },
      {
        "id": 214554,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">HBPM (Home Blood Pressure Monitoring) </span></span></span></p>"
      },
      {
        "id": 214555,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">OBPM (Office Blood Pressure Monitoring) </span></span></span></p>"
      },
      {
        "id": 214556,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">All of the above</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 48-year-old woman visits her primary care physician for an annual health examination. Her blood pressure is measured as 135/85 mmHg, with no prior history of hypertension. The physician schedules two additional blood pressure measurements over the next month. Which of the following methods is the physician using to diagnose hypertension?</span></span></p>",
    "unique_key": "Q6918631",
    "question_audio": null,
    "question_video": null,
    "map_id": 25365,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) OBPM (Office Blood Pressure Monitoring)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The vignette describes the standard practice of <strong>OBPM</strong>, where blood pressure is measured multiple times in the clinical setting over a period to confirm a diagnosis of hypertension. This is done to account for the variability of blood pressure and to rule out &quot;white coat hypertension.&quot;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. ABPM (Ambulatory Blood Pressure Monitoring):</span></strong><span style=\"font-size:12.0pt\">&nbsp;This involves continuous blood pressure monitoring over 24 hours using a wearable device.&nbsp;It is more precise than OBPM but not the method described in the vignette.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. HBPM (Home Blood Pressure Monitoring):</span></strong><span style=\"font-size:12.0pt\">&nbsp;This involves the patient measuring their blood pressure at home using their own device.&nbsp;While valuable,&nbsp;the vignette does not mention the patient taking measurements at home.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. All of the above:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This is incorrect as the vignette only describes the use of OBPM in a clinical setting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The initial diagnosis of hypertension typically relies on <strong>Office Blood Pressure Monitoring (OBPM)</strong>, where multiple readings are taken in a clinical setting over a period of time to confirm the diagnosis and rule out white coat hypertension. While ABPM and HBPM are valuable tools for monitoring blood pressure and assessing its patterns, they are not typically the first step in diagnosing hypertension.</span></span></span></p>",
    "correct_choice_id": 214555,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 53771,
    "choices": [
      {
        "id": 214557,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">White coat hypertension </span></span></span></p>"
      },
      {
        "id": 214558,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Masked hypertension </span></span></span></p>"
      },
      {
        "id": 214559,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Primary hypertension </span></span></span></p>"
      },
      {
        "id": 214560,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Secondary hypertension</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 54-year-old man with a family history of hypertension has normal clinic blood pressure readings (128/82 mmHg) but 24-hour ambulatory monitoring reveals consistently elevated readings (135-145/85-90 mmHg). What is the most likely diagnosis?</span></span></p>",
    "unique_key": "Q1357675",
    "question_audio": null,
    "question_video": null,
    "map_id": 25366,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Masked hypertension</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Masked hypertension is defined by normal blood pressure in the clinic but elevated readings outside of it,&nbsp;as confirmed by the ambulatory monitoring in this case.&nbsp;This suggests that the patient&#39;s blood pressure is elevated in daily life,&nbsp;but the clinic setting artificially lowers it,&nbsp;potentially due to factors like the calming effect of the healthcare environment or the short duration of measurement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. White coat hypertension</span></strong><span style=\"font-size:12.0pt\">:&nbsp;This is the opposite of masked hypertension,&nbsp;where blood pressure is elevated in the clinic but normal outside.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Primary hypertension</span></strong><span style=\"font-size:12.0pt\">:&nbsp;While this patient likely has hypertension,&nbsp;the term &quot;primary&quot; doesn&#39;t account for the specific pattern seen here with normal clinic readings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Secondary hypertension</span></strong><span style=\"font-size:12.0pt\">:&nbsp;This refers to hypertension caused by an underlying medical condition,&nbsp;which is not indicated in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The diagnosis in this case is <strong>masked hypertension</strong>, characterized by normal blood pressure readings in a clinical setting but elevated readings during ambulatory monitoring. This highlights the importance of using ambulatory monitoring to accurately assess blood pressure and diagnose hypertension, especially in individuals with a family history of hypertension or other risk factors.</span></span></span></p>",
    "correct_choice_id": 214558,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 53772,
    "choices": [
      {
        "id": 214561,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Masked hypertension </span></span></span></p>"
      },
      {
        "id": 214562,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">White coat hypertension </span></span></span></p>"
      },
      {
        "id": 214563,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Primary hypertension </span></span></span></p>"
      },
      {
        "id": 214564,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Secondary hypertension</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 47-year-old woman with well-controlled type 2 diabetes presents for a routine health examination. Her in-office blood pressure is 142/88 mmHg, but her average blood pressure at home over two weeks is 122/78 mmHg. She reports feeling nervous during medical appointments. Which of the following is the most likely diagnosis?</span></span></p>",
    "unique_key": "Q2955251",
    "question_audio": null,
    "question_video": null,
    "map_id": 25367,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) White coat hypertension</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">White coat hypertension</span></strong><span style=\"font-size:12.0pt\">&nbsp;is defined as elevated blood pressure readings in the clinic setting,&nbsp;while out-of-office readings (e.g.,&nbsp;home blood pressure monitoring) are normal.&nbsp;This phenomenon is often attributed to anxiety or stress related to the medical environment.&nbsp;The patient&#39;s report of feeling nervous at medical appointments supports this diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Masked hypertension:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This is the opposite of white coat hypertension,&nbsp;with normal clinic readings but elevated blood pressure outside the clinic.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Primary hypertension:</span></strong><span style=\"font-size:12.0pt\">&nbsp;While this patient may eventually develop sustained hypertension,&nbsp;the current findings are not consistent with this diagnosis.&nbsp;Primary hypertension would typically present with consistently elevated readings in both clinic and home settings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Secondary hypertension:</span></strong><span style=\"font-size:12.0pt\">&nbsp;This refers to hypertension caused by an underlying medical condition,&nbsp;such as renal artery stenosis or pheochromocytoma.&nbsp;There is no indication of secondary hypertension in this patient&#39;s history or presentation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The diagnosis in this case is <strong>white coat hypertension</strong>, where blood pressure readings are elevated in a clinical setting but normal at home. This is often caused by anxiety or stress related to the medical environment, which the patient reports experiencing.</span></span></span></p>",
    "correct_choice_id": 214562,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 53773,
    "choices": [
      {
        "id": 214565,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Beta-blocker (e.g., propranolol) </span></span></span></p>"
      },
      {
        "id": 214566,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Alpha-blocker (e.g., phenoxybenzamine) </span></span></span></p>"
      },
      {
        "id": 214567,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Calcium channel blocker (e.g., amlodipine) </span></span></span></p>"
      },
      {
        "id": 214568,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Angiotensin-converting enzyme inhibitor (e.g., lisinopril)</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old man with a pheochromocytoma scheduled for surgical resection presents with a blood pressure of 180/100 mmHg and episodic headaches and sweating. Which of the following medications should be initiated pre-operatively?</span></span></p>",
    "unique_key": "Q1125617",
    "question_audio": null,
    "question_video": null,
    "map_id": 25368,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Alpha-blocker (e.g., phenoxybenzamine)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Alpha-blockers are the first-line therapy for pre-operative blood pressure control in pheochromocytoma.&nbsp;They antagonize the vasoconstrictive effects of catecholamines released by the tumor,&nbsp;preventing hypertensive crises during surgery and reducing the risk of intraoperative complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Beta-blocker:</span></strong><span style=\"font-size:12.0pt\">&nbsp;Beta-blockers should be avoided initially as they can worsen hypertension by causing unopposed alpha-adrenergic stimulation.&nbsp;They may be added later for tachycardia control&nbsp;<em>after</em>&nbsp;adequate alpha-blockade is established.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Calcium channel blocker:</span></strong><span style=\"font-size:12.0pt\">&nbsp;While calcium channel blockers have antihypertensive effects,&nbsp;they are not the first-line agents for pheochromocytoma and are less effective in controlling the episodic hypertension caused by catecholamine surges.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Angiotensin-converting enzyme inhibitor (ACE inhibitor):</span></strong><span style=\"font-size:12.0pt\">&nbsp;ACE inhibitors are not recommended for initial blood pressure control in pheochromocytoma,&nbsp;as they do not directly address the underlying catecholamine excess and may not effectively control blood pressure fluctuations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Alpha-blockers are the first-line medication for pre-operative blood pressure control in patients with pheochromocytoma. They counteract the effects of catecholamines released by the tumor, preventing hypertensive crises during surgery.</span></span></span></p>",
    "correct_choice_id": 214566,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 53774,
    "choices": [
      {
        "id": 214569,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Patent ductus arteriosus </span></span></span></p>"
      },
      {
        "id": 214570,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atrial septal defect </span></span></span></p>"
      },
      {
        "id": 214571,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Coarctation of the aorta </span></span></span></p>"
      },
      {
        "id": 214572,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ventricular septal defect</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following congenital cardiovascular conditions is most commonly associated with hypertension in children and young adults?</span></span></p>",
    "unique_key": "Q8665984",
    "question_audio": null,
    "question_video": null,
    "map_id": 25369,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Coarctation of the aorta</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Coarctation of the aorta is a congenital narrowing of the aorta, typically located near the ductus arteriosus. This narrowing obstructs blood flow to the lower extremities, leading to higher blood pressure in the upper extremities and potentially causing hypertension. It is often detected in childhood or young adulthood due to symptoms like headaches, dizziness, or leg pain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Patent ductus arteriosus (PDA):</span></strong><span style=\"font-size:12.0pt\">&nbsp;While PDA can cause heart murmurs and other symptoms,&nbsp;it doesn&#39;t typically cause hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Atrial septal defect (ASD):</span></strong><span style=\"font-size:12.0pt\">&nbsp;ASD is a hole in the wall separating the atria,&nbsp;and it usually doesn&#39;t cause significant hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Ventricular septal defect (VSD):</span></strong><span style=\"font-size:12.0pt\">&nbsp;VSD is a hole in the wall separating the ventricles.&nbsp;It can cause heart failure if large,&nbsp;but doesn&#39;t typically cause isolated hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Coarctation of the aorta is the most common congenital heart defect associated with hypertension in children and young adults. This narrowing of the aorta increases blood pressure before the constriction and can lead to various symptoms.</span></span></span></p>",
    "correct_choice_id": 214571,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 53775,
    "choices": [
      {
        "id": 214573,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Moderate alcohol consumption has no effect on blood pressure. </span></span></span></p>"
      },
      {
        "id": 214574,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Drinking three or more alcoholic drinks per day is associated with lower blood pressure. </span></span></span></p>"
      },
      {
        "id": 214575,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Reducing alcohol consumption can lead to a decrease in blood pressure. </span></span></span></p>"
      },
      {
        "id": 214576,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Alcohol consumption has no impact on the risk of stroke.</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements about alcohol consumption and blood pressure is TRUE?</span></span></p>",
    "unique_key": "Q6556063",
    "question_audio": null,
    "question_video": null,
    "map_id": 25370,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Reducing alcohol consumption can lead to a decrease in blood pressure.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Excessive alcohol intake is associated with higher blood pressure, and reducing alcohol consumption can lower blood pressure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Moderate alcohol consumption has no effect on blood pressure</span></strong><span style=\"font-size:12.0pt\">: Moderate alcohol consumption may have a slight effect on blood pressure, but it is not considered neutral.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12pt\">Option B.</span><span style=\"font-size:14.6667px\">&nbsp;</span></strong><strong style=\"font-size:11pt\"><span style=\"font-size:12.0pt\">Drinking three or more alcoholic drinks per day is associated with lower blood pressure</span></strong><span style=\"font-size:12pt\">: Excessive alcohol intake is associated with&nbsp;<em>higher</em>, not lower, blood pressure.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Alcohol consumption has no impact on the risk of stroke</span></strong><span style=\"font-size:12.0pt\">: Excessive alcohol intake is a risk factor for stroke.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Excessive alcohol consumption is a modifiable risk factor for hypertension. Reducing alcohol intake can lead to a decrease in blood pressure, improving overall cardiovascular health and reducing the risk of stroke.</span></span></span></p>",
    "correct_choice_id": 214575,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 53776,
    "choices": [
      {
        "id": 214577,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Serum creatinine and estimated glomerular filtration rate (eGFR) </span></span></span></p>"
      },
      {
        "id": 214578,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Serum electrolytes </span></span></span></p>"
      },
      {
        "id": 214579,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fasting blood glucose </span></span></span></p>"
      },
      {
        "id": 214580,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Renin-aldosterone ratio</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 68-year-old woman with a history of diabetes and hypertension presents for a routine check-up. Her blood pressure is 150/95 mmHg. Which of the following laboratory tests is NOT routinely recommended as part of the initial evaluation of hypertension?</span></span></p>",
    "unique_key": "Q7278940",
    "question_audio": null,
    "question_video": null,
    "map_id": 25371,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Renin-aldosterone ratio</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The renin-aldosterone ratio is a specialized test used to evaluate for primary aldosteronism, a rare cause of secondary hypertension. It is not routinely recommended for the initial evaluation of hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Serum creatinine and estimated glomerular filtration rate (eGFR), Option B. Serum electrolytes, </span></strong><span style=\"font-size:12.0pt\">and<strong> Option C. Fasting blood glucose</strong>: Serum creatinine, eGFR, electrolytes, and fasting blood glucose are all part of the basic laboratory tests recommended for the initial evaluation of hypertension. They help assess renal function, electrolyte balance, and underlying conditions like diabetes that can contribute to hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The initial evaluation of hypertension focuses on assessing end-organ damage (kidneys), identifying contributing factors (electrolytes, diabetes), and establishing a baseline for monitoring the patient&#39;s condition.</span></span></span></p>",
    "correct_choice_id": 214580,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 53777,
    "choices": [
      {
        "id": 214581,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Headache </span></span></span></p>"
      },
      {
        "id": 214582,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fatigue </span></span></span></p>"
      },
      {
        "id": 214583,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Palpitations </span></span></span></p>"
      },
      {
        "id": 214584,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Epistaxis (nosebleed)</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is NOT a typical symptom of hypertension?</span></span></p>",
    "unique_key": "Q3080469",
    "question_audio": null,
    "question_video": null,
    "map_id": 25372,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Palpitations</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypertension is often asymptomatic, hence the term &quot;silent killer.&quot; Headaches, fatigue, and epistaxis can sometimes be associated with hypertension, but they are not specific symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Headache,&nbsp;Option B. Fatigue&nbsp;</span></strong><span style=\"font-size:12.0pt\">and</span><strong><span style=\"font-size:12.0pt\">&nbsp;Option D. Epistaxis (nosebleed)</span></strong><span style=\"font-size:12.0pt\">:&nbsp;These symptoms can sometimes be associated with hypertension,&nbsp;although they are not specific</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Recognize</span></strong><span style=\"font-size:12.0pt\"> that hypertension is often asymptomatic and emphasize the importance of regular blood pressure checks for early detection and management.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Differentiate</span></strong><span style=\"font-size:12.0pt\"> between potential, but not typical, symptoms of hypertension (headache, fatigue, epistaxis) and symptoms not typically associated with hypertension (palpitations).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Highlight</span></strong><span style=\"font-size:12.0pt\"> the importance of considering other potential causes for these nonspecific symptoms when evaluating a patient.</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 214583,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 53778,
    "choices": [
      {
        "id": 214585,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Obesity </span></span></span></p>"
      },
      {
        "id": 214586,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Abdominal bruit </span></span></span></p>"
      },
      {
        "id": 214587,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Retinal arteriolar narrowing </span></span></span></p>"
      },
      {
        "id": 214588,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">S4 gallop</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following physical examination findings is most suggestive of secondary hypertension?</span></span></p>",
    "unique_key": "Q4200576",
    "question_audio": null,
    "question_video": null,
    "map_id": 25373,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Abdominal bruit</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">An abdominal bruit (abnormal sound heard on auscultation) can suggest renal artery stenosis, a common cause of secondary hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12pt\">Option A.</span><span style=\"font-size:14.6667px\">&nbsp;</span></strong><strong style=\"font-size:11pt\"><span style=\"font-size:12.0pt\">Obesity</span></strong><span style=\"font-size:12pt\">: Obesity is a risk factor for primary hypertension.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Retinal arteriolar narrowing</span></strong><span style=\"font-size:12.0pt\">: Retinal arteriolar narrowing is a sign of hypertensive retinopathy,&nbsp;a consequence of hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. S4 gallop</span></strong><span style=\"font-size:12.0pt\">: S4 gallop can be heard in hypertensive heart disease but is not specific for secondary hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Abdominal bruit is a significant finding on physical examination that should raise suspicion for secondary hypertension, specifically renal artery stenosis.</span></span></span></p>",
    "correct_choice_id": 214586,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 53779,
    "choices": [
      {
        "id": 214589,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><a name=\"_Hlk174438414\"><span style=\"font-size:12.0pt\">Immediate BP reduction to normal with IV drugs. </span></a></span></span></p>"
      },
      {
        "id": 214590,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gradual BP reduction to 25% of initial value over 24 hours. </span></span></span></p>"
      },
      {
        "id": 214591,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ICU admission for aggressive BP control. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>"
      },
      {
        "id": 214592,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Discharge with outpatient follow-up.</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old man with hypertension presents with a blood pressure of 210/120 mmHg, headache, and mild dyspnea. He has no evidence of acute organ damage. What is the best management strategy?</span></span></p>",
    "unique_key": "Q7092881",
    "question_audio": null,
    "question_video": null,
    "map_id": 25374,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Gradual BP reduction to 25% of initial value over 24 hours.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This is a hypertensive urgency (high BP without organ damage). Rapid BP lowering can be dangerous, so a gradual reduction is preferred.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.</span></strong> <strong><span style=\"font-size:12.0pt\">Immediate BP reduction to normal with IV drugs</span></strong><span style=\"font-size:12.0pt\">: Immediate reduction to normal BP is too aggressive for a hypertensive urgency and could cause ischemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. ICU admission for aggressive BP control</span></strong><span style=\"font-size:12.0pt\">: ICU admission is unnecessary as there is no evidence of organ damage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Discharge with outpatient follow-up</span></strong><span style=\"font-size:12.0pt\">: Discharge without treatment is inappropriate due to the severity of the hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The distinction between hypertensive urgency and emergency is crucial for appropriate management. Hypertensive urgency requires gradual blood pressure reduction, while hypertensive emergency necessitates rapid intervention to prevent end-organ damage.</span></span></span></p>",
    "correct_choice_id": 214590,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 53780,
    "choices": [
      {
        "id": 214593,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Intravenous sodium nitroprusside </span></span></span></p>"
      },
      {
        "id": 214594,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Oral clonidine </span></span></span></p>"
      },
      {
        "id": 214595,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Intravenous labetalol </span></span></span></p>"
      },
      {
        "id": 214596,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Sublingual nifedipine</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 72-year-old woman with a history of hypertension and chronic kidney disease presents with a blood pressure of 200/120 mmHg and acute visual disturbances. Which of the following is the most appropriate medication for initial blood pressure control in this scenario?</span></span></p>",
    "unique_key": "Q3921174",
    "question_audio": null,
    "question_video": null,
    "map_id": 25375,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Intravenous labetalol</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Labetalol is a combined alpha- and beta-blocker that provides rapid and controlled blood pressure reduction in hypertensive emergencies. It is particularly useful in patients with underlying renal disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Intravenous sodium nitroprusside</span></strong><span style=\"font-size:12.0pt\">: Sodium nitroprusside is a potent vasodilator,&nbsp;but it can cause cyanide toxicity,&nbsp;especially in patients with renal insufficiency.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Oral clonidine</span></strong><span style=\"font-size:12.0pt\">: Oral clonidine is not used in hypertensive emergencies due to its slow onset of action.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Sublingual nifedipine</span></strong><span style=\"font-size:12.0pt\">: Sublingual nifedipine is associated with unpredictable blood pressure drops and is not recommended.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intravenous labetalol is a preferred medication for initial blood pressure control in hypertensive emergencies, especially in patients with underlying renal disease.</span></span></span></p>",
    "correct_choice_id": 214595,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 53781,
    "choices": [
      {
        "id": 214597,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Nitroprusside </span></span></span></p>"
      },
      {
        "id": 214598,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hydralazine </span></span></span></p>"
      },
      {
        "id": 214599,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Enalaprilat </span></span></span></p>"
      },
      {
        "id": 214600,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Phentolamine</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old pregnant woman in her third trimester presents with a blood pressure of 170/110 mmHg and proteinuria. Which of the following medications is most appropriate for controlling her blood pressure?</span></span></p>",
    "unique_key": "Q6716652",
    "question_audio": null,
    "question_video": null,
    "map_id": 25376,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong> <strong><span style=\"font-size:12.0pt\">B) Hydralazine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient has preeclampsia/eclampsia, a hypertensive emergency in pregnancy. Hydralazine is a safe and effective vasodilator for this condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Nitroprusside</span></strong><span style=\"font-size:12.0pt\">:&nbsp;Should be avoided in pregnancy due to the risk of cyanide toxicity to the fetus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Enalaprilat (an ACE inhibitor)</span></strong><span style=\"font-size:12.0pt\">:&nbsp;Contraindicated in pregnancy due to the risk of fetal harm.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.</span></strong> <strong><span style=\"font-size:12.0pt\">Phentolamine</span></strong><span style=\"font-size:12.0pt\">:&nbsp;Not typically used for hypertension in pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hydralazine is a safe and effective vasodilator for controlling blood pressure in pregnant women with preeclampsia/eclampsia.</span></span></span></p>",
    "correct_choice_id": 214598,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 53784,
    "choices": [
      {
        "id": 214609,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">ACEi + ARB + CCB </span></span></span></p>"
      },
      {
        "id": 214610,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">BB + ACEi + Spironolactone </span></span></span></p>"
      },
      {
        "id": 214611,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">BB + CCB + Thiazide </span></span></span></p>"
      },
      {
        "id": 214612,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ARB + Thiazide + Spironolactone</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 65-year-old man with hypertension and a recent myocardial infarction (MI) is being discharged from the hospital. Which medication combination is most appropriate for his secondary prevention?</span></span></span></p>",
    "unique_key": "Q8438830",
    "question_audio": null,
    "question_video": null,
    "map_id": 25379,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) BB + ACEi + Spironolactone</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The image indicates BB + A (ACEi) + spironolactone for HTN with MI. This combination is supported by evidence for mortality reduction post-MI.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The </span><strong><span style=\"font-size:12.0pt\">other options</span></strong><span style=\"font-size:12.0pt\"> either lack evidence for post-MI benefit or include combinations that could be harmful (e.g., ACEi + ARB).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This combination is recommended for secondary prevention in patients with hypertension and a recent MI due to strong evidence for mortality reduction.</span></span></span></p>",
    "correct_choice_id": 214610,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 53785,
    "choices": [
      {
        "id": 214613,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Amlodipine </span></span></span></p>"
      },
      {
        "id": 214614,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Hydrochlorothiazide </span></span></span></p>"
      },
      {
        "id": 214615,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Losartan </span></span></span></p>"
      },
      {
        "id": 214616,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Metoprolol</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 55-year-old woman with a history of hypertension and migraines presents for follow-up. Which antihypertensive medication would be most suitable given her comorbidities?</span></span></span></p>",
    "unique_key": "Q5351490",
    "question_audio": null,
    "question_video": null,
    "map_id": 25380,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Metoprolol</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Beta-blockers are indicated for both hypertension and migraine prophylaxis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options</span></strong><span style=\"font-size:12.0pt\"> do not have the dual indication.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Beta-blockers are the only class of antihypertensives indicated for both hypertension and migraine prophylaxis.</span></span></span></p>",
    "correct_choice_id": 214616,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 53790,
    "choices": [
      {
        "id": 214633,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Lisinopril </span></span></span></p>"
      },
      {
        "id": 214634,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Losartan </span></span></span></p>"
      },
      {
        "id": 214635,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Labetalol </span></span></span></p>"
      },
      {
        "id": 214636,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Amlodipine</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 35-year-old pregnant woman is diagnosed with gestational hypertension. Which of the following antihypertensive medications is considered safe for use during pregnancy?</span></span></span></p>",
    "unique_key": "Q5025274",
    "question_audio": null,
    "question_video": null,
    "map_id": 25385,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Labetalol</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Labetalol is the first-line medication for gestational hypertension due to its safety profile in pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. ACE inhibitors (Lisinopril)</span></strong><span style=\"font-size:12.0pt\"> and </span><strong><span style=\"font-size:12.0pt\">Option B. ARBs (Losartan)</span></strong><span style=\"font-size:12.0pt\"> are contraindicated in pregnancy due to fetal risks. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Amlodipine:&nbsp;</span></strong><span style=\"font-size:12.0pt\">The safety of </span><strong><span style=\"font-size:12.0pt\">amlodipine</span></strong><span style=\"font-size:12.0pt\"> and hydrochlorothiazide during pregnancy is not well established.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Labetalol is the first-line medication for gestational hypertension due to its established safety profile in pregnancy. ACE inhibitors and ARBs are contraindicated.</span></span></span></p>",
    "correct_choice_id": 214635,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 53793,
    "choices": [
      {
        "id": 214645,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Oral amlodipine </span></span></span></p>"
      },
      {
        "id": 214646,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Oral furosemide </span></span></span></p>"
      },
      {
        "id": 214647,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">IV labetalol </span></span></span></p>"
      },
      {
        "id": 214648,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">IV furosemide</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">What is the first line treatment of hypertensive emergency? </span></span></span></p>",
    "unique_key": "Q6249000",
    "question_audio": null,
    "question_video": null,
    "map_id": 25388,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) IV labetalol</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IV labetalol is a beta-blocker with alpha-blocking properties that is commonly used in the initial treatment of hypertensive emergencies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Oral amlodipine</span></strong><span style=\"font-size:12.0pt\">: Oral medications are not indicated in emergency situations. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Oral furosemide</span></strong><span style=\"font-size:12.0pt\"> and </span><strong><span style=\"font-size:12.0pt\">Option D. IV furosemide:</span></strong><span style=\"font-size:12.0pt\"> IV furosemide is a diuretic and may be used as an adjunct, but not as the primary treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IV labetalol is a common first-line treatment for hypertensive emergencies due to its rapid onset and combined alpha- and beta-blocking effects.</span></span></span></p>",
    "correct_choice_id": 214647,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 53794,
    "choices": [
      {
        "id": 214649,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atenolol (beta-blocker) </span></span></span></p>"
      },
      {
        "id": 214650,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lisinopril (ACE inhibitor) </span></span></span></p>"
      },
      {
        "id": 214651,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Amlodipine (calcium channel blocker) </span></span></span></p>"
      },
      {
        "id": 214652,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hydrochlorothiazide (thiazide diuretic) e) Losartan (ARB)</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old man with a history of hypertension and chronic obstructive pulmonary disease (COPD) requires an additional antihypertensive medication. Which of the following would be the most appropriate choice given his comorbidities?</span></span></p>",
    "unique_key": "Q1822960",
    "question_audio": null,
    "question_video": null,
    "map_id": 25389,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Amlodipine (calcium channel blocker)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Beta-blockers (atenolol) are generally avoided in patients with COPD due to the potential for bronchoconstriction. The other options are reasonable, but CCBs are often preferred due to their neutral effect on lung function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The </span><strong><span style=\"font-size:12.0pt\">other options</span></strong><span style=\"font-size:12.0pt\"> may be less suitable due to potential adverse effects on lung function or lack of evidence for specific benefits in COPD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Calcium channel blockers are often preferred in patients with hypertension and COPD due to their neutral effect on lung function, while beta-blockers should be used with caution.</span></span></span></p>",
    "correct_choice_id": 214651,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  }
];
        let quizName = 'Nephrology';
        let hierarchy = ["Cerebellum", "qBank", "Medicine"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - QuizMaster Pro';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        const urlParams = new URLSearchParams(window.location.search);
        currentQuestionIndex = Math.min(parseInt(urlParams.get('startAt')) || 0, questionsData.length - 1);

        function goBack() {
            if (isQuizCompleted || confirm('Are you sure you want to leave the quiz? Your progress will be lost.')) {
                window.history.back();
            }
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                setTimeout(processAnswer, 300);
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            setTimeout(showSolution, 1500);
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (!window.location.pathname.endsWith('custom_quiz.html')) {
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>